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Abstract 
Regulatory interactions that occur between Polo-like kinase 1 (Plk1) and its 
protein partners are critical for promoting many different cell division events.  
Indeed, Plk1 is found mis-regulated in a diverse set of human cancers and has 
been clinically validated as a drug target in cancer.  Here, we use Drosophila as 
a model to understand how a 217 amino acid protein called Matrimony (Mtrm) 
regulates the Drosophila homolog of Plk1, Polo kinase, during female meiosis. 
By analyzing the functionality of a variety of Mtrm mutants, we find that Mtrm and 
Polo appear to engage in a non-canonical mechanism of interaction in vivo 
relative to previously described Polo protein interactors.  Furthermore, we have 
identified a Mtrm mutant that separates function during meiosis, suggesting that 
Mtrm may differentially interact with Polo kinase by at least two different 
pathways or mechanisms. Thus, in addition to furthering our understanding of the 
role of Mtrm as a regulator of Polo in Drosophila female meiosis, these studies 
address a larger, more fundamental question of how Polo interacts with its 
protein partners in vivo.  Elucidating such non-canonical mechanisms of Polo 
regulation in vivo may contribute to the development of novel and innovative 
strategies for selective Plk1 inhibition in cancer. 
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Chapter 1.  Introduction 
1.1 Why study Polo kinase regulation? 
Successful cell division requires a series of carefully coordinated events to 
occur in time and space including DNA replication, alignment of sister 
chromosomes on the spindle, segregation of genetic material to each of the 
daughter cells, and then disassembly of the spindle and cytokinesis.  Temporal 
and spatial control of these events is achieved in part by the coordinated action 
of multiple kinases. One such kinase is the highly conserved Polo-like kinase 1 
(Plk1), which is increasingly recognized as a master promoter of many cell 
division events (for reviews, see [1-4]).  Furthermore, Plk1 is mis-regulated in 
human cancers of diverse origins and has been clinically validated as a selective 
drug target in cancer [5-8].  Therefore, we reason that understanding how Plk1 is 
regulated in vivo is important for elucidating how this kinase performs its 
numerous roles during cell division.  In addition, this work may also contribute to 
the development of innovative strategies for targeted Plk1 inhibition as an anti-
cancer therapy.   
1.1.1 Polo kinase—“The Multi-tasking kinase” 
The discovery of Plk1 began with the isolation of a mutant in Drosophila 
melanogaster that displayed abnormal mitotic spindle poles [9].  The mutation 
was mapped to a gene (later named polo) encoding a serine/threonine kinase 
that is highly conserved from budding yeast (Cdc5) to humans (Plk1) [10].   Since 
its discovery in 1988, the known roles of Plk1 orthologs (hereafter collectively 
 
 
 2 
called Polo kinases) in cell division have rapidly expanded to include proper 
mitotic/meiotic entry, regulation of centriole duplication and centrosome 
maturation, biorientation of chromosomes, regulation of cohesion, control of 
mitotic exit and cytokinesis (Figure 1-1).  The various functions of this multi-
tasking kinase have been the subject of many extensive reviews [1-4]. 
          
Figure 1-1  Summary of Plk1 functions in the cell cycle. 
This figure, adapted from [11], summarizes the functions of Plk1 during various aspects of mitotic 
progression including mitotic entry, centriole and centrosome maturation, proper chromosome 
segregation, mitotic exit and cytokinesis.  Inhibitory interactions are shown in red and stimulatory 
interactions are shown as black arrows.  
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While these initial studies pointed to a clear role for Polo in promoting 
mitotic and meiotic events during cell division, they also raised an interesting 
question: how can Polo perform such a diverse array of tasks from the beginning 
to the end of cell division?  The answer, in part, involves its dynamic post-
translational regulation aside from transcriptional control and targeted 
degradation (reviewed in [1-4]).  Not only is Polo kinase able to phosphorylate its 
targets, it also engages in noncatalytic phosphoprotein interactions that facilitate 
its dynamic subcellular localization within the cell.  The ability of Polo kinase to 
participate in two major mechanisms of signal transduction—phosphorylation and 
phosphoprotein binding–is a remarkable property that has only been shown to 
exist for only a handful of signaling proteins thus far [12].  Proper subcellular 
localization of Polo through noncatalytic means effectively gives the kinase 
access to its catalytic targets at the proper time and place during cell division.  
Conversely, such localization would also effectively restrict the kinase from its 
substrates at the wrong time and place.  This special aspect of Polo kinase will 
be described in more detail in Sections 1.2 and 1.3.  
1.1.2 Clinical Implications 
From a clinical standpoint, this work is important because Plk1 is found 
dramatically mis-regulated in a diverse set of human cancers.  It is not surprising 
that mis-regulation of such a central protein kinase could override critical 
checkpoints leading to improper cell division and aneuploidy, which is linked to 
tumorigenesis [13,14].  Plk1 overexpression has been observed in a number of 
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human cancers including non-small-cell lung cancer [15], head and neck cancer 
[16], esophageal cancer [17], gastric cancer [18], melanomas [19], breast cancer 
[20], ovarian cancer [21], cervical cancer [22],  colorectal cancer [23], glioma [24], 
papillary carcinoma [25], pancreatic cancer [26,27], prostate cancer [28,29], 
leukemias and lymphomas [30-32], bladder cancer [33] and thyroid cancer [34], 
among others (for list and reviews, see [35-37]).   
Paradoxically, Plk1 down-regulation has also been implicated in 
tumorigenesis.  Increased tumor development has been observed in Plk1+/- mice 
[38].  However, this observation may reflect the essential role of Plk1 during 
embryogenesis, when Plk1 expression is required for rapid cellular proliferation 
and differentiation [38].  Nevertheless, the observation that both overexpression 
and down-regulation of Plk1 may lead to tumorigenesis suggests that the tight 
regulation of this kinase is essential for proper cell division (for review, see [35]). 
Many studies have clinically validated Plk1 as drug target in cancer [5-8].  
Currently, two general strategies are being pursued for selective Plk1 inhibition 
by small molecules.  The first involves a classical method of kinase inhibition by 
targeting the ATP-binding pocket responsible for rendering the kinase 
catalytically active.  Indeed, considerable success has been achieved using this 
approach [39,40] (for review, see [41]).  However, due to the high degree of 
structural conservation among ATP-binding pockets, identifying inhibitors that 
selectively target the Plk1 ATP-binding pocket has proven challenging.   
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The second approach involves targeting the unique domain of Polo 
responsible for mediating the noncatalytic protein-protein interactions that 
facilitate its dynamic subcellular localization.  One potential advantage to the 
second approach is that, unlike the ATP-competitive inhibitors, targeting this 
unique Polo domain may minimize undesirable off-target effects.  On this front, 
progress has also been made in identifying small molecules that inhibit Polo 
activity via this domain [42-44] (for review, see [41]).   However, as we continue 
to advance our basic understanding of how Polo noncatalytically interacts with its 
protein partners in vivo, we are finding that the mechanisms of interaction are 
more varied and complex than previously thought.  This suggests that identifying 
new and innovative approaches for non-competitive Polo inhibition is entirely 
plausible, and perhaps even likely. Advancing our basic knowledge of how Polo 
interacts with its protein partners in vivo may help to drive those discoveries.  
1.2 Evolutionarily conserved structure of Polo kinase 
Further discussion requires a more detailed examination of the structure of 
Polo kinase, which is highly conserved from budding yeast (Cdc5) to humans 
(Plk1) (Figures 1-2 and 1-3).  Polo kinase is comprised of two functional 
domains—a canonical N-terminal serine/threonine kinase domain and a unique 
C-terminal Polo-box domain (PBD) separated by a flexible linker region (Figure 
1-2).   While the crystal structure of each domain has been determined 
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individually, a complete structure of the entire protein has not been reported to 
date (see [41] for review). 
The N-terminal kinase domain of Polo targets proteins that contain the 
consensus motif (D/E-X-pS/pT-Ø-X-D/E), in single amino acid code, where X is 
any amino acid, p denotes phosphorylation, and Ø is any hydrophobic amino 
acid.  Crystal structures of the kinase domain of Polo reveal typical kinase 
domain topology, where phosphorylation of its activation loop occurs at T210 of 
human Plk1 (T182 in Drosophila Polo) (Figure 1-3).  While the kinase topology is 
grossly canonical, several modest structural modifications within the Polo ATP-
binding pocket are observed.  These changes may contribute to the success in 
developing selective ATP-competitive inhibitors such as BI 2536, which shows 
high selectivity for Plk1 versus other serine/threonine kinases [39,47].  
 
Figure 1-2  Structure of Polo kinase.   
(A) Plk1 is comprised of an N-terminal kinase domain and a C-terminal noncatalytic PBD separated 
by a flexible linker region.  (B) Adapted from [48].  Two Polo boxes, PB1 and PB2, form the C-
terminal PBD.  The PBD is thought to bind phosphopeptides comprised of a specific core 
consensus motif, which functions to spatially and temporally regulate the protein’s catalytic activity 
during cell division [45,46]. 
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The C-terminal noncatalytic Polo box-domain (PBD) is unique to Polo and 
mediates protein-protein interactions that allow the kinase to multi-task within the 
cell.  The C-terminal PBD consists of two Polo boxes, PB1 and PB2, which 
function as a single protein-binding unit.  A shallow, positively charged cleft is 
formed at the interface of the two Polo boxes, which has been reported to 
selectively bind phosphopeptides containing a specific core consensus motif (S-
pS/pT-P/X), where p denotes phosphorylation and X is any amino acid (Figure 1-
2) [45,46]. 
Moreover, multiple studies in several organisms have identified several 
mutations that abrogate the ability of the PBD to selectively bind proteins.  The 
classic ‘pincer mutant’ was first identified as an H538A/K540M double mutant 
residing within PB2 [46].  Additional studies have revealed several mutations 
within PB1 that also abrogate PBD selectivity including W414F, V415A and 
L427A of human Plk1 [48].  The equivalent mutations in Drosophila Polo are 
W395F, V396A, and L408A and have been shown to abrogate function within 
this organism [49]. Because these mutations ablate PBD specificity, they often 
largely impair Polo function within the cell. 
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1.3 Polo Regulation via the C-terminal Polo-box domain 
Although early studies suggested that the C-terminal PBD of Polo strictly 
interacts with phosphopeptides containing a canonical S-pS/pT-P/X motif [45,46], 
it is becoming increasingly clear that the PBD can interact with regulatory 
proteins via non-canonical mechanisms as well (for review, see [50]).  This 
emerging view of the PBD as a versatile mediator of several types of protein-
protein interactions may more accurately explain the intricacies of how this 
kinase is able to multi-task so efficiently during cell division.  It also suggests that 
PBD function is not fully understood and will be a worthwhile endeavour for years 
to come. Furthermore, certain Polo functions could be reduced or abrogated 
while leaving others intact, opening up the possibility for novel therapeutic 
strategies. 
1.3.1 Canonical mechanisms of interaction 
Several reports have validated the canonical method of Polo-protein 
interaction that is dependent on a S-pS/pT-P/X motif within the Polo protein 
interactor.  One such example involves the interaction between Plk1 and Bub1 in 
mitotic HeLa cells, where phosphorylation of Bub1 at a threonine within a 
conserved S-pT-P PBD binding motif is critical for proper localization of 
endogenous Plk1 to kinetochores during mitosis.  Furthermore, this interaction is 
dependent on the PBD, as the Plk1 H538A/K540M ‘pincer mutant’ is unable to 
co-immunoprecipitate (co-IP) with Bub1 [51].  Another example involves PICH, a 
centromere-associated SNF2 family ATPase.  PICH is thought to recruit Plk1 to 
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kinetochores during prometaphase in HeLa cells through phosphorylation of a 
threonine within a canonical PBD binding motif by Cdk1 [52].  Several other 
examples have been reported and are thoroughly reviewed in [50], but probably 
the most thoroughly characterized canonical PBD dependent Polo-protein 
interaction is that of Plk1 and Cdc25C.  Phosphorylation of Cdc25C of an S-pT-P 
PBD binding motif residing within the protein allows for PBD binding and 
subsequent activation of Cdc25C via Plk1-mediated phosphorylation—a critical 
event for mitotic entry [46]. 
1.3.2 Non-canonical mechanisms of interaction 
Although Polo binding to the S-pT-P motif of Cdc25C is one of the first 
characterized examples of PBD-phosphoprotein interaction, additional studies 
have reported contradictory findings.   More specifically, Elia et al. reported that 
phosphorylation of this site is necessary for interactions with the PBD, however, 
a second report demonstrated that the PBD can functionally bind equally well to 
a nonphosphorylated version of Cdc25C [46,53].  The nature of this discrepancy 
is not clear; however, it is the first of several published works suggesting that the 
PBD can interact with proteins in a more complex manner than initially proposed.  
A similar mechanism of non-canonical interaction with the PBD was 
demonstrated in Drosophila S2 cells.  In these cells, Polo kinase robustly 
interacts with microtubule-associated protein, Map205, during interphase of the 
cell cycle by a phospho-independent mechanism, which is thought to allow for 
proper timing of mitotic entry [49].   
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In addition to the proposed phosphorylation requirement of the central 
residue within the PBD binding motif, several reports demonstrated that the 
serine at the – 1 position relative to the central residue is also critical for binding 
[46,54].  Nevertheless, exceptions have been discovered.  One such example is 
the interaction between Plk1 and MKlp2 in HeLa cells, which serves to localize 
Plk1 to the central spindle/midbody in order to regulate cytokinesis [55].  While 
this particular interaction does appear to be phospho-dependent (in fact, Plk1 is 
thought to phosphorylate its own PBD binding site in this case), the determined 
sequence for PBD binding is H-pS-L within MKlp2.  
Other cases exist where robust PBD binding to target proteins is reported 
despite the lack of a recognizable S-pS/pT-P/X motif.  For example, the yeast 
protein Dbf4 has been described to interact with the yeast homolog of Polo 
(Cdc5) that potentially facilitates proper mitotic exit under certain circumstances 
via a non-canonical mechanism [56].  Interestingly, Dbf4 appears to phospho-
independently interact with the Cdc5 PBD through a novel R-S-I-E-G-A Dbf4 
amino acid sequence.  Moreover, the PBD ‘pincer mutant’ robustly interacts with 
Dbf4 as assayed by yeast two-hybrid (Y2H), suggesting that Dbf4 may use a 
distinct binding surface to interact with the PBD.  Other examples of non-
canonical Polo-protein interactions include Bora and Plk1, which act together 
with Aurora A kinase to regulate mitotic entry in HeLa cells.  The specific PBD 
binding site on Bora has not been determined.  However, the interaction appears 
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to occur independently of phosphorylation.  Furthermore, Bora appears to be 
capable of interacting with both the kinase domain and the PBD of Plk1 [57].   
Perhaps the most intriguing aspect of Polo regulation via the C-terminal 
PBD involves auto-regulation (reviewed in [58] and [50]). Currently the 
intramolecular basis of how the PBD domain interacts with the kinase domain 
remains unclear. The kinase domain lacks a recognizable PBD binding motif, 
suggesting that the mechanism of interaction is non-canonical.  Furthermore, 
dephosphorylation of the T-loop within the kinase domain may facilitate self-
interaction with the PBD resulting in a closed, inactive configuration state.  
Phosphorylation of the T-loop may relieve this mutually inhibitory interaction, 
returning Polo kinase to an open configuration state, where the kinase domain is 
active and the PBD is free to bind other regulatory partners.  Overall, these and 
other examples (reviewed in [50]) serve to illustrate the complexity of noncatalytic 
Polo-protein interactions.  Clearly, future studies are necessary to elucidate how 
these varied regulatory interactions influence Polo activity within the cell. 
1.4 Evolutionarily conserved structure of Matrimony (Mtrm) 
The mtrm gene was isolated in a deficiency screen for Drosophila mutants 
that fail in homologous achiasmate chromosome segregation—a process that 
normally ensures proper homolog segregation in the absence of genetic 
exchange [59].  Importantly, this phenotype is fully suppressed by simultaneously 
reducing the dosage of the polo gene, suggesting that Mtrm may regulate Polo 
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during Drosophila female meiosis.  Furthermore, Mtrm and Polo physically 
interact in vivo as assayed by biochemical and proteomic analysis in the fly [60]. 
Of note, this finding is consistent with an independent study, which identified 
Mtrm and Polo kinase as interactors in a global Y2H study that screened 102 D. 
melanogaster bait proteins orthologous to human cancer-related and/or signaling 
proteins against high-complexity fly cDNA libraries [61].  This topic will be further 
discussed in Section 1.5.  Here we address our goal of understanding precisely 
how Mtrm may physically interact with Polo by first examining its predicted 
structure. 
Mtrm is a 217 amino acid protein that is evolutionarily conserved throughout 
the genus Drosophila.  Indeed, Mtrm homologs have been identified in the 11 
other sequenced species of Drosophila, indicating that this protein has been 
conserved for approximately 30 million years.  Using an amino acid sequence 
alignment of the homologs, we observed that Mtrm can be parsed into three 
blocks of sequence that are conserved throughout the 12 sequenced Drosophila 
species.  One block surrounds an S-T40-P sequence that fits a canonical PBD 
consensus motif (S-pT/pS-P/X) hereafter named the ‘STP region’, one is located 
just proximal to the C-terminal sterile alpha motif (SAM) domain, and one 
coincides with the SAM domain itself (Figure 1-4).  
Previous work has shown that mutating MtrmT40 to alanine both ablates 
Mtrm function and its ability to interact with Polo kinase [60].  However, whether 
the PBD binding motif alone is sufficient to mediate the interaction between Mtrm 
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and Polo remained unclear.  Moreover, the use of NetPhosK software revealed 
several other potentially important consensus motifs within Mtrm [62] (see top of 
Figure 1-4). Two nearby serines, MtrmS48 and MtrmS52, fall within a consensus 
motif for Glycogen synthase kinase 3 β (GSK-3β) phosphorylation (pS/pT-X-X-X-
pS), which has been shown to play important roles in cell division [63].  Other 
motifs include a partially conserved cyclin B-Cdk1 phosphorylation motif (pS/pT-
P-X-R/K), where the phospho-residue would be MtrmS66.  In addition, MtrmS137 
falls within a near perfect consensus motif for Polo phosphorylation (D/E-X-
pS/pT-Ø-X-D/E).  This of interest as Polo has been proposed to phosphorylate its 
own PBD targets such as MKlp2.    
We also find that key residues within the C-terminal SAM domain are 
conserved, however, the functionality of the Mtrm SAM domain remains unclear.  
Intriguingly, proteins that harbour SAM domains are involved in a set of 
remarkably diverse functions that result from SAM domain-mediated interactions 
between other proteins, DNA and RNA [64-66]. 
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Examination of the amino acid sequence and the predicted secondary 
structure of the region proximal to the SAM domain prompted speculation that 
part of Mtrm may be intrinsically unstructured.   Intrinsially unstructured proteins 
are both abundant and functionally important in eukaryotes—their inherent lack 
of secondary and/or tertiary protein structure confers increased flexibility, which 
allows for a wide range of functions including many processes during cell division 
[67].  We utilized FoldIndex to predict whether this may be the case for Mtrm, and 
we found that the entire protein proximal to the SAM domain is predicted to be 
intrinsically unstructured [68] (Figure 1-5). For comparison, the program also 
correctly predicted several smaller intrinsically unstructured regions within Polo, 
particularly the flexible linker region between the N-terminal kinase domain and 
the C-terminal PBD, which is consistent with previous structural analyses. (Figure 
1-5).  The likelihood of Mtrm being intrinsically unstructured allows us to 
speculate how this protein may be physically capable of interacting with Polo.  In 
addition, this analysis also supports a rational strategy for site-directed 
mutagenesis of residues within the region of Mtrm proximal to the SAM domain.  
Lower structural complexity confers structural permissiveness, which decreases 
the probability that a given mutation within this region will cause protein 
misfolding and subsequent degradation [69]. 
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1.5 The role of the mtrm gene product in Drosophila female 
meiosis 
Perhaps one of the more interesting aspects of this work is our focus on 
examining the physical interaction between Mtrm and Polo in its native context—
Drosophila female meiosis.  Drosophila female meiosis is an ideal model for 
exploring Polo regulation in vivo.  Depletion of the mtrm gene causes several 
well-described meiotic consequences in vivo.  More importantly, evidence 
suggests that the meiotic defects observed in females lacking the proper dosage 
of mtrm are a consequence of Polo misregulation.   
          
Figure 1-5  FoldIndex predicts Mtrm to contain a large intrinsically unstructured region.  
(A)  Mtrm contains a large unstructured region proximal to the C-terminal SAM domain.  Because 
lower structural complexity confers structural permissiveness, site directed mutagenesis within this 
region of the protein is likely to be permitted without protein misfolding and subsequent 
degradation.  (B) For comparison, Drosophila Polo was predicted to have an unstructured linker 
region separating the N-terminal kinase domain and the C-terminal PBD, which is consistent with 
structural studies of Polo. 
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1.5.1 Female meiosis—a specialized form of cell division 
Meiosis is a specialized form of cell division that differs from mitosis since 
DNA replication is followed by two rounds of cell division:  Meiosis I (MI) and 
Meiosis II (MII).  The first division, MI, separates homologous chromosome pairs, 
and the second division, MII, separates sister chromatids resulting in a haploid 
cell ready for fertilization.  For many years, female meiotic cells (oocytes) have 
been successfully used to elucidate the basic mechanisms of cell division for 
several reasons.  First, oocytes are characteristically larger than other cells, often 
providing easily accessible material for biochemical and cytological analysis.  
Secondly, unlike cells undergoing mitosis or male meiosis that quickly complete 
division upon M phase entry, the vast majority of female meiotic systems 
undergo two pre-programmed mid-cycle arrests.  In a way, one can imagine 
these arrests as exaggerated versions of what happens during mitosis and male 
meiosis.  Thus, in essence, female meiosis could be viewed as a specialized 
form of cell division that provides a larger window of opportunity by which to 
study the mechanisms of cell division control (for reviews, see [70,71]). 
Drosophila female meiosis is an ideal model for understanding the basics of 
cell division.  First, D. melanogaster carries the obvious advantage of being a 
highly genetically tractable model organism with a long history of focus on 
chromosome segregation during MI of female meiosis, when homologous 
chromosome pairs align and separate.  Much more concise than the human 
genome, which is comprised of 23 homologous pairs of chromosomes, the 
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Drosophila genome is comprised of only 4 chromosome pairs.  Nevertheless, in 
Drosophila oocytes, like most organisms, genetic exchange or chiasmata 
formation between homologous chromosome pairs during MI serves to physically 
lock them together, thus facilitating their proper alignment and co-orientation on 
the metaphase plate [72-74].   
Surprisingly, cases also exist where genetic exchange (or recombination) 
either fails or occurs at a lower frequency, and yet proper homologous 
chromosome segregation remains intact.  This observation led to the discovery 
and characterization of a remarkably efficient ‘back-up’ mechanism that facilitates 
proper chromosome segregation in the absence of exchange or chiasmata 
formation.  This system was initially discovered in Drosophila and coined ‘the 
distributive system’ by Rhoda Grell in 1962 [75], and is now recognized more 
generally as ‘homologous achiasmate segregation’ [76] (Figure 1-6). Studying 
the mechanism by which non-exchange chromosome are faithfully segregated is 
of importance as recent reports indicate that approximately 1 in 5 human oocytes 
that contain an extra chromosome 21 have failed to recombine with its homolog 
[77,78].  Trisomy 21 is the most common chromosomal abnormality observed in 
humans, and yet the rate is significantly lower than 1 in 5 births, strongly 
suggesting that an achiasmate system may also exist in humans. 
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Since its discovery in 1962, the biology of homologous achiasmate 
segregation has been observed in several other meiotic systems, but remains 
most extensively studied in the fly (for review, see [79]).  This is at least partly 
due to several convenient aspects of Drosophila chromosomal biology as well 
our ability to readily manipulate the Drosophila genome.  For example, the fourth 
chromosomes of Drosophila are always achiasmate during female meiosis.  
Additionally, the X chromosomes can be genetically manipulated to be obligately 
achiasmate by creating flies heterozygous for a normal sequence X chromosome 
and a chromosome containing multiple inversions, known as a balancer 
chromosome.  Inversions within the balancer chromosome (such as FM7) 
                       
Figure 1-6  Homologous chromosome segregation during female meiosis.  
Genetic exchange serves the important mechanistic role of facilitating the segregation of 
homologous chromosomes at M1 of female meiosis. However, chromosome pairs that fail to 
undergo exchange for one reason or another may still faithfully segregate through the 
process of homologous achiasmate segregation.   
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effectively suppress exchange or recombination with the normal sequence 
homolog.  Due to the process of homologous achiasmate segregation, both the 
genetically manipulated X homologs and the fourth homologs are still able to 
faithfully segregate away from each other during MI [76]. This observation has 
allowed us to perform large genetic screens to identify genes critical for 
achiasmate chromosome segregation. 
Drosophila female meiosis is also an ideal model for understanding the 
basic mechanisms of cell cycle control since they undergo similar pre-
programmed developmental arrests as other female meiotic systems (for review, 
see [70].  While the second arrest in Drosophila female meiosis occurs at 
metaphase of MI rather than metaphase of MII in humans, the first arrest at 
prophase of MI is the same as humans as well as the vast majority of all other 
female meiotic systems.  Moreover, the unique anatomy of the Drosophila 
ovariole allows for the simultaneous characterization of oocytes in all stages of 
development up to the second arrest, when all four homologous chromosome 
pairs must be properly aligned and co-oriented on the metaphase plate (Figure 1-
7). 
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1.5.2 Effects of mtrm depletion 
Just before the global Y2H screen identified the gene product CG18543 as 
a putative Polo kinase interactor [61], it was isolated in a Drosophila screen of 
autosomal deficiencies for dominant effects on homologous achiasmate 
segregation [59].  CG18543 was subsequently renamed matrimony (mtrm) since 
it appeared to be critical for holding chromosome pairs together for a substantial 
period of time.  In 2007, the critical role for mtrm in homologous achiasmate 
segregation was functionally linked to polo [60].  The high levels of achiasmate 
chromosome nondisjunction (NDJ) observed in Drosophila females heterozygous 
for a null allele of mtrm could be fully rescued by simultaneous reduction of the 
polo gene by one copy.  Furthermore, as mentioned previously, mutating the 
central residue of the PBD binding motif within Mtrm, MtrmT40, to alanine both 
 
Figure 1-7  The Drosophila ovariole provides a snapshot of oocyte development.  
Adapted from [60].  The unique anatomy of the D. melanogaster ovariole allows us to examine 
oocytes in all stages of development including those stages in which the pre-programmed and 
highly conserved Prophase I arrest occurs.  The termination of Prophase I arrest is defined by 
nuclear envelope breakdown (NEB), which normally occurs at stage 13 of Drosophila oocytes 
development.   
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ablates Mtrm function (as assayed by homologous achiasmate segregation) and 
its ability interact with Polo kinase [60].   
Additionally, Xiang et al. found that Drosophila females heterozygous or 
homozygous for a null allele of mtrm also exhibited precocious nuclear envelope 
breakdown (NEB) in a dosage-dependent manner, suggesting that the timing of 
the cessation of prophase I arrest was perturbed [60].  Furthermore, this defect 
was also rescued by simultaneous reduction of the polo gene or by simultaneous 
reduction of Polo’s downstream target, Cdc25 (twine) [60] (for review, see [80]).  
These data are consistent with a large collection of reports implicating Polo 
kinase as the ‘trigger’ kinase leading to CyclinB-Cdk1 activation, which acts to 
dismantle the nuclear envelope in many organisms or to promote mitotic/meiotic 
entry in those organisms that undergo ‘closed’ cell division with an intact nuclear 
envelope [81-83].  For example, work in S. cerevisiae, S. pombe, and X. laevis 
revealed that Polo kinase promotes mitotic entry by phosphorylating Cdc25, 
which in turn activates Cyclin B-Cdk1 [81-83].  A similar theme is also seen in 
female meiosis.  In C. elegans oocytes, silencing of plk-1 expression in by RNA-
mediated interference (RNAi) significantly delays NEB, which can be 
phenocopied by silencing the C. elegans Cdk1 ortholog via RNAi [84].  
Furthermore, work in X. laevis oocytes revealed that Plx1 (Polo kinase in X. 
laevis) functions to activate Cdc25 and CyclinB-Cdk1 [85].   
Considering these two phenotypes, it seemed possible that the 
achiasmate chromosome nondisjunction phenotype could be a direct 
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consequence of the precocious NEB phenotype.  Thus, in addition to testing 
whether D. melanogaster oocytes simultaneously heterozygous for a null allele 
mtrm and a null allele of the meiotic version of Cdc25 (twine) rescued the NEB 
phenotype, Xiang et al. also examined whether these oocytes exhibited 
suppression of the achiasmate nondisjunction phenotype.  Surprisingly, they 
found that while the NEB phenotype could be rescued in this genetic 
background, the achiasmate NDJ phenotype could not.  These data suggest that 
the two phenotypes observed in oocytes lacking the proper dosage of mtrm may 
be functionally separate albeit both Polo-mediated, potentially serving to highlight 
the high degree of complexity of Polo regulation in vivo.  
1.5.3 Mtrm as a negative regulator of Polo kinase 
As stated above, previous work in yeast and flies demonstrates that Mtrm 
physically interacts with Polo kinase.  Importantly, both meiotic phenotypes 
observed in females lacking sufficient levels of mtrm are suppressed by 
simultaneously reducing the dosage of polo, which suggests that Mtrm is a 
negative regulator of Polo kinase.  Thus, considering that Mtrm and Polo 
physically interact via Y2H and by co-IP in Drosophila ovarian lysates, it is 
possible that Mtrm may negatively regulate Polo kinase during Drosophila female 
meiosis via direct physical interaction. 
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1.6 Summary 
Polo kinase is a critical promoter of multiple events during cell division, is 
overexpressed in many human cancers, and has been validated as a selective 
target for inhibition as an anti-cancer therapy.  Therefore, understanding the 
mechanisms of its regulation in vivo is fundamentally important.  Although initial 
studies suggested that post-translational Polo regulation largely occurs by a 
specific type of non-catalytic interaction between the C-terminal Polo PBD and 
phosphoproteins containing a specific S-pS/pT-P/X motif, more recent studies 
suggest that ‘non-canonical’ interactions between Polo and its regulatory 
partners also exist.  Understanding the mechanisms of these ‘non-canonical’ 
interactions may lead to novel strategies for targeted Polo inhibition in cancer. 
Mtrm is a 217 amino acid protein that post-translationally regulates Polo 
kinase during Drosophila female meiosis.  An amino acid sequence alignment of 
Mtrm homologs from 12 sequenced Drosophila species representing 
approximately 30 million years of evolution reveals that this protein can be 
parsed into three blocks of highly conserved sequence.  One block surrounds an 
S-T40-P sequence that fits a canonical PBD consensus motif, one is located just 
proximal to the C-terminal sterile alpha motif (SAM) domain, and one coincides 
with the SAM domain itself.  Previous work showed that the central residue of the 
PBD binding motif is critical for Mtrm function and physical interaction with Polo 
kinase in vivo, but whether this motif alone is sufficient for physical interaction in 
vivo remains unclear.  Furthermore, it appears that the functions of Mtrm during 
 
 
 26 
Drosophila female meiosis may be separable, albeit both Polo-related, raising the 
intriguing possibility that Mtrm could regulate Polo kinase by multiple pathways or 
mechanisms. 
1.7 Scope of this thesis 
1.7.1 Examining the interaction between Mtrm and Polo in vivo 
This work addresses whether the physical interaction between Mtrm and 
Polo is ‘canonical’ or ‘non-canonical’ with respect to other known Polo protein 
interactors.  We first utilize S. cerevisiae as a means by which to explore the 
effects of multiple Mtrm and Polo mutants on their ability to physically interact via 
Y2H.  We then further validate our findings by in vivo studies in the fly using 
newly available site-specific transgenic techniques.  By studying this interaction 
in D. melanogaster, we are able to examine various Mtrm related meiotic 
phenotypes observed in Drosophila females lacking sufficient levels of the mtrm 
gene.   
1.7.2 Questions to be addressed 
This thesis begins with experiments utilizing S. cerevisiae as an in vivo 
test tube to demonstrate that Mtrm and Polo may interact by a ‘non-canonical’ 
mechanism.  The validity of these findings is demonstrated by creating the same 
series of Mtrm mutants integrated into a specific site in the D. melanogaster 
genome and then examining the ability of these mutants to physically interact 
with endogenous Polo kinase during female meiosis via proteomic analysis.  We 
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then address whether Mtrm separation-of-function mutants can be identified by 
screening for the ability of a large class of Mtrm mutants targeting evolutionarily 
conserved residues to rescue the homologous achiasmate segregation defects 
observed in Drosophila females heterozygous for a null allele of mtrm and/or the 
sterility defects observed in Drosophila females homozygous for a null allele of 
mtrm.  This is achieved by usage of well-established Drosophila genetic 
techniques designed to specifically examine both homologous achiasmate 
segregation and oocyte development. 
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Chapter 2.  Analysis of the physical interaction between 
Mtrm and Polo kinase in S. cerevisiae 
2.1 Introduction 
As mentioned in Chapter 1, the physical interaction between Mtrm and Polo 
was initially reported in a global yeast two-hybrid (Y2H) screen for Drosophila 
interacting proteins [61], and experiments in the fly verified the interaction to be 
functionally critical for several aspects of female meiosis [60].  The Y2H system 
offers many advantages.  Most importantly, it offers a means to study protein-
protein interactions in a live, eukaryotic environment with greater speed than 
would be possible in the fly.  Thus, we returned to analysis in yeast to dissect the 
nature of the physical interaction between Mtrm and Polo.  This chapter will 
describe a study that identifies specific residues/regions of Mtrm and Polo that 
may be important for their interaction during Drosophila female meiosis.  The 
results of the study allowed us to focus on point or deletion mutants of Mtrm that 
potentially have the most effect on Drosophila female meiosis, the topic of 
Chapters 3, 4 and 5.   
Because Polo kinase is highly conserved, we also addressed the question 
of whether Mtrm is able to physically interact with the budding yeast homolog of 
Polo, Cdc5. 
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2.2 Yeast two-hybrid analysis of Mtrm mutants 
Y2H is a method to analyze protein-protein interactions in a eukaryotic cell, 
namely the budding yeast Saccharomyces cerevisiae.  The results discussed in 
this section use two sets of chimeric proteins, one chimera that is a fusion with 
the DNA-binding domain (BD) of the yeast transcription factor, Gal4, and the 
other that is joined with the Gal4 activation domain (AD).  In the Y2H system 
used in the following experiments, the BD binds to the GAL1 upstream activation 
sequence (UAS), which contains four Gal4 binding sites.  The AD, derived from 
the C-terminal 113 amino acids of Gal4, facilitates transcription via RNA 
polymerase II.  As the BD and the AD activities are separate and independent, 
the two domains only need to be in close proximity to each other to activate gene 
transcription. Therefore, the interaction between two proteins of interest fused to 
a BD and an AD respectively can be determined by whether or not gene 
transcription occurs. Here, the GAL1 UAS is used to drive expression of a 
reporter gene, HIS3. When a functional interaction occurs, HIS3 is transcribed, 
and cells are able to grow on media lacking histidine.  If no binding occurs, HIS3 
is not produced and the yeast cells die. In addition, growth of cells is assayed on 
media lacking leucine and tryptophan, which ensures presence of the 2u 
plasmids containing the AD and the BD fusion proteins, respectively.    
As shown in Figure 2-1, the growth of diploid yeast cells with plasmids 
encoding Mtrm-AD and Polo-BD on SC-His-Leu-Trp plates demonstrates that the 
yeast-two hybrid assay confirms the interaction between full-length Mtrm and 
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Polo.  Strains carrying mtrm-AD or polo-BD genes in addition to the respective 
AD or BD (vector only) control genes are unable to grow.  Thus, Mtrm-AD does 
not bind significantly to the Gal4 binding site, nor does Polo-BD act as an 
activator (Figure 2-1).   
In order to determine which Mtrm residues/regions are required for Polo 
interaction via Y2H, we constructed a C-terminal truncation deleting the Mtrm 
SAM domain.  In addition, a series of point mutants were made that would disrupt 
Mtrm residues predicted to fall within known phosphorylation motifs (MtrmS48A, 
MtrmS52A, MtrmS66A and MtrmS137A) and/or previously shown to be 
potentially significant in the fly (MtrmT40A).  
As shown in Figure 2-1, the lack of colony growth of strains expressing 
Polo-BD and MtrmSAMDEL-AD on the SC-His-Leu-Trp medium suggests that 
the C-terminal SAM domain of Mtrm contributes to the physical interaction 
between Mtrm and Polo via Y2H.  Furthermore, strains expressing Polo-BD and 
MtrmS48A-AD or MtrmS52A-AD (mutants of residues that fall within a putative 
GSK-3β phosphorylation motif and that have been found reproducibly 
phosphorylated in the fly) also showed reduced growth (Figure 2-1).  Therefore, 
we conclude that these residues play a role in Mtrm’s interaction with Polo. 
By contrast, colony growth of strains carrying Polo-BD and MtrmS66A-AD 
or MtrmS137A-AD is robust under selective conditions and resembles that of the 
positive control, Mtrm-AD (Figure 2-1).  These results suggest that neither 
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MtrmS66, which lies within a putative CyclinB-Cdk1 phosphorylation, nor 
MtrmS137, which is located within a near perfect Polo phosphorylation motif 
have significant roles in Mtrm-Polo binding.  Lastly and surprisingly, the strains 
expressing Polo-BD and MtrmT40A-AD, which disrupts an absolutely conserved 
core PBD-binding motif previously shown to be critical for homologous 
achiasmate segregation in the fly, are able to grow on selective media (Figure 2-
1).  Therefore, in the context of the Y2H system, MtrmT40 appears dispensable 
for its binding to Polo kinase.   
Taken together, these data provide the first evidence that Mtrm may interact 
with Polo in a fashion that does not solely depend on a canonical PBD-binding 
motif, but may also depend on the C-terminal SAM domain and other 
phosphorylatable residues such as MtrmS48 and MtrmS52. 
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2.3 Yeast two-hybrid analysis of Polo mutants 
We took a similar approach in order to determine whether specific Polo 
residues were required for physical interaction with Mtrm via Y2H.  We targeted 
amino acids within the T-loop of the protein’s kinase domain and the C-terminal 
PBD that have previously shown to be essential for Polo activity in vivo.  
Replacement of the phosphorylatable residue of the T-loop, PoloT182, with 
alanine is predicted to yield a kinase dead mutant.  The mutations PoloH518A 
and PoloK520M disrupt the selectivity of the PBD and are equivalent to the 
‘pincer mutant’ identified in Plk1.  Additionally, we constructed a 
PoloH518A/K520M double mutant (Polo-HK) and a PoloT182A/H518A/K520M 
           
Figure 2-1  Y2H reveals key Mtrm residues/regions required to physically interact with             
Polo.  
Mtrm residues either predicted to be post-translationally modified by NetPhosK software or 
determined to be important experimentally were mutated to alanine and then tested for a Y2H 
interaction with Polo.  10-Fold serial dilutions of saturated cultures were spotted onto SCM/-Trp-
Leu plates to visualize cells and confirm presence of both plasmids and Scm/-Trp-Leu-His to 
score the two-hybrid interaction. 
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triple mutant (Polo-THK).  Surprisingly, while PoloT182A appears to have a 
diminished ability to interact with Mtrm, the mutants that are known to disrupt 
PBD selectivity (PoloH518A, PoloK520M and Polo-HK) as well as the triple 
mutant, Polo-THK, which has both the kinase domain and the PBD altered, were 
all able to interact with Mtrm-AD. (Figure 2-2).  Considering that the ‘pincer 
mutant’ is predicted to ablate PBD specificity, these results suggest that Mtrm 
and Polo may interact by some non-canonical mechanism, perhaps similar to 
what has been described between Dbf4 and the yeast Polo homolog, Cdc5 [56].   
  
Figure 2-2  Y2H reveals Polo residues critical for PBD selectivity are dispensable for 
interaction with Mtrm.  
Polo residues critical for functionality were mutated and then tested for a Y2H interaction 
with Mtrm.  10-Fold serial dilutions of saturated cultures were spotted onto SCM/-Trp-Leu 
plates to visualize cells and confirm presence of both plasmids and Scm/-Trp-Leu-His to 
score the two-hybrid interaction. 
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2.4 Heterologous Mtrm expression in S. cerevisiae 
Several possible explanations exist as to why Mtrm might interact with 
kinase dead versions of Polo, such as Polo-THK.  First, the budding yeast 
homolog of Polo Cdc5 may be able to phosphorylate Mtrm and therefore bypass 
the requirement for Polo phosphorylation. Alternatively, other kinases may modify 
Mtrm to allow for interactions between Mtrm and Polo in yeast. Finally, a yeast 
protein might bridge the interaction between Mtrm and Polo, one possible 
candidate being Cdc5 itself. 
To address these possibilities, we purified a Mtrm-3xFLAG fusion protein 
from yeast cells that expressed the protein from the galactose-inducible GAL1 
promoter using FLAG resin. These cells also contained a Myc-tagged version of 
Cdc5 under the control of its endogenous promoter (SLJ917, gift of the 
Jaspersen Lab). Our initial co-immunoprecipitation experiments suggested that 
perhaps a very weak interaction existed between Mtrm-3xFLAG and Myc-Cdc5 
(see Section 2.4.1).  However, multidimensional protein identification technology 
(MudPIT) mass spectrometry analysis more supported the view that Mtrm does 
not appear to robustly interact with Cdc5.  Moreover, MudPIT analysis also 
demonstrated that Mtrm-3XFLAG does not appear to interact with any other 
yeast protein (see Section 2.4.2). Furthermore, post-translational modification 
analysis of purified Mtrm-3XFLAG reveals that Mtrm is phosphorylated similarly 
in yeast as in the fly (see Section 2.4.3).  Overall, these data ultimately support 
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the view that the Y2H interaction between Mtrm and Polo likely reflects a direct, 
physical interaction. 
2.4.1 Co-immunoprecipitation assays of Mtrm and Cdc5 in yeast 
In order to determine whether Mtrm is able to interact with the yeast 
homolog of Polo, Cdc5, we performed reciprocal co-immunoprecipitation assays 
by inducibly expressing and immunoaffinity purifying a Mtrm-3XFLAG protein 
from a WT yeast strain (SLJ001, gift of the Jaspersen Lab) and a strain 
containing Myc-tagged version of Cdc5 under the control of its endogenous 
promoter (SLJ917, gift of the Jaspersen Lab).  Mtrm-3XFLAG appeared to non-
specifically bind to Myc immunoaffinity beads in a WT background, (see Figure 2-
3 panel A Lane 1), rendering the results observed in panels C and D, Lanes 1 
likely an artifact.  Utilization of FLAG immunoaffinity beads appeared to 
potentially co-immunoprecipitate a small amount of Myc3-Cdc5. (see Figure 2-3, 
panels C and D, Lanes 3).  Furthermore, Myc3-Cdc5 did not appear to non-
specifically bind to FLAG beads alone (Figure 2-3, panels C and D, Lanes 4).   
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2.4.2 MudPIT analysis of Mtrm expressed in yeast 
In order to address whether other yeast proteins including the yeast 
homolog of Polo, Cdc5, co-purified with Mtrm in yeast, we performed multi-
dimensional protein identification technology (MudPIT) mass spectrometry 
                 
Figure 2-3  Co-Immunoprecipitation assays of Mtrm-3XFLAG and Myc3-Cdc5 in 
yeast.  
Cell lysates from either a WT strain or a Myc3-CDC5 strain expressing Mtrm-3XFLAG 
under the GAL1 promoter were induced with galactose or repressed with dextrose, 
immunoaffinity purified using either FLAG or Myc beads and subjected to Western analysis.  
Panels A and B show analysis of Mtrm-3XFLAG expressed in a WT strain.  Panels C and D 
show analysis in a Myc3-CDC5 background.  Panel A Lane 1 shows that Mtrm-3XFLAG 
non-specifically binds to Myc beads, rendering the co-immunoprecipitation results in panels 
C and D, Lane 1 likely artifactual.  A small amount of Myc3-Cdc5, however, appears to co-
immunoprecipitate with Mtrm-3XFLAG (panels C and D, Lane 3). The lanes marked M 
shows the Bio-Rad Precision Plus Pre-stained Protein Ladder used.  (Other bands marked 
with an asterisk at approximately 55 kDa and 25 kDa represent residual heavy and light 
chains from the immunoaffinity purification.) 
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analysis on a Mtrm-3XFLAG fusion protein inducibly expressed and FLAG-
purified from yeast also containing Myc-tagged version of Cdc5 under the control 
of its endogenous promoter (SLJ97). The details of MudPIT will be described 
more in more detail in Chapter 3.  As shown in Figure 2-3, we did not visualize 
any pertinent bands other than that corresponding to Mtrm-3XFLAG by silver 
staining 5% of protein eluates after galactose induction, anti-FLAG agarose 
immunoaffinity purification and subsequent 3XFLAG peptide elutions (see panel 
A, Lanes 6-8). 
         
Figure 2-4  Silver stain of Mtrm-3XFLAG immunoaffinity purified from yeast.  
Cell lysates from a Myc3-CDC5 strain expressing Mtrm-3XFLAG under the control of the GAL1 
promoter induced with galactose or repressed with dextrose (panels A and B, respectively) and 
subjected to FLAG immunoaffinity purification and silver staining (Invitrogen SilverExpress).  Lane 
4 represents flow through following FLAG immunoaffinity purification.  Lane 5 represents the first 
wash following purification.  Lanes 6-8 represent 5% of the first, second and third 3XFLAG peptide 
elutions following purification washes, respectively.  Mtrm-3XFLAG protein is eluted following 
galactose induction (~37 kDa band). However, no other pertinent bands were visible via silver 
stain.  The lane marked M shows the Invitrogen BenchMark Protein Ladder used.  (Other bands in 
Lanes 6-8 at approximately 55 kDa and 25 kDa represent residual heavy and light chains from the 
immunoaffinity purification.) 
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We performed MudPIT analysis on the remaining 95% of the first and 
second eluates following galactose induction and dextrose repression.  Two 
sequential elutions for each case were analyzed to allow for one technical 
replicate each.  Consistent with the silver stain, MudPIT analysis revealed that no 
proteins of interest differentially co-purified with the samples induced with 
galactose (containing Mtrm-3xFLAG protein) versus the dextrose only (No FLAG 
protein) control.  Also, no peptides were detected that covered Myc3-Cdc5.  
Table 2-1  MudPIT analysis of Mtrm-3XFLAG expressed in yeast. 
Cell lysates from a Myc3-CDC5 strain expressing Mtrm-3XFLAG under the control of the GAL1 
promoter induced with galactose or repressed in dextrose, subjected to FLAG immunoaffinity 
purification and MudPIT mass spectrometry.  The table shows the number of peptides (P), 
spectra (S), sequence coverage (SC) and normalized spectral abundance factor (NSAF) for the 
top 25 iteracting proteins detected.   In total, 4 samples were analyzed:  two sequential elutions 
following galactors induction (blue) and two sequential elutions following dextrose induction 
(gray).  Mtrm-3XFLAG was, by far, the most abundant protein identified in the mixture, with the 
majority of other interacting proteins being ribosomal in nature. 
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2.4.3 Post-translational modification analysis of Mtrm expressed in yeast 
By combining the two MudPIT runs expressing Mtrm3x-FLAG following 
galactose induction, we were able to achieve approximately 72% sequence 
coverage of the protein.  This allowed us to perform post-translational analysis of 
Mtrm to determine whether the protein is phosphorylated similarly in yeast and 
fly.  While MtrmT40 was not phosphorylated on Mtrm3X-FLAG purified from the 
Myc3-CDC5 yeast strain, MtrmS52 was reproducibly phosphorylated, which is 
consistent with previous PTM studies of Mtrm purified from ovarian lysates [60].  
Furthermore, the phosphorylation status of MtrmS52 is intriguing in light of our 
Y2H results, which demonstrate that mutation of this residue to non-
phosphorylatable alanine renders the protein unable to interact with Drosophila 
Polo in yeast. 
Table 2-2  Phosphorylated sites detected on Mtrm-3XFLAG expressed in yeast. 
MtrmS52 was found reproducibly phosphorylated when Mtrm is expressed in yeast.  Because 
this residue is also found highly phosphoyrlated in the fly [60]  
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2.5 Discussion 
The Y2H experiments described in Chapter 2 of this thesis provide the first 
evidence that Mtrm may interact with Polo in a fashion that does not solely 
depend on the core PBD-binding motif.  Analysis of various Mtrm mutants 
revealed that the physical interaction may also depend on the C-terminal SAM 
domain and other phosphorylatable residues such as MtrmS48 and MtrmS52.  
Interestingly (in the context of the Y2H assays), MtrmT40, which falls within an 
absolutely conserved PBD binding motif appears to be dispensable.  Whether or 
not this reflects the sensitive nature of the assay itself or is a consequence of 
analyzing the interaction in a heterologous system remains unclear. 
Additional evidence supporting the view that Mtrm and Polo may interact in 
a non-canonical mechanism includes the analysis of various Polo mutants via 
Y2H.  The results described in Figure 2-2 suggest that Mtrm may interact with 
Polo via a surface that is distinct from the canonical PBD binding pocket as the 
‘pincer mutant’ predicted to ablate PBD specificity is still able to interact with 
Mtrm.  This intriguing finding suggests that Mtrm and Polo may interact by some 
mechanism, perhaps similar to that described between Dbf4 and the yeast Polo 
homolog, Cdc5, where Dbf4 is thought to bind to a distinct binding surface on the 
PBD.   
Of note, the PoloT182A mutant has a reduced ability to bind Mtrm, while the 
PoloTHK triple mutant appears to engage in robust interaction.  An explanation 
for this may be obtained if we consider the current model by which Polo is 
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thought to fold into a ‘closed’ configuration state, where the PBD interacts with 
the kinase domain when the T-loop is not phosphorylated.  Perhaps PoloT182A 
is folded into its ‘closed’ configuration state, thereby rendering it unable to 
interact with Mtrm.  Intriguingly, the PoloTHK triple can still robustly bind to Polo, 
begging the speculation that the triple mutant is open configuration state.  If so, 
then the data suggest that perhaps PoloH518 and PoloK520 contribute to 
establishing or maintaining the mutual inhibitory ‘closed’ configuration of Polo. 
In this chapter, we also addressed the possibility that Mtrm is able to 
physically interact with the yeast homolog of Polo, Cdc5.  Multidimensional 
protein identification technology (MudPIT) mass spectrometry analysis 
definitively showed that Mtrm does not appear to robustly interact with Cdc5.  
More importantly, MudPIT analysis also demonstrated that Mtrm-3XFLAG likely 
does not interact with any other yeast protein, supporting the view that the 
interaction between Mtrm and Polo is likely direct.  However, it should be noted 
that the reciprocal MudPIT study was not performed on an epitope tagged 
version of Drosophila Polo expressed in yeast.  Additionally, we cannot rule out 
the possibility that wash conditions were too stringent to maintain any pertinent 
weak interactions.  Finally, post-translational modification analysis of Mtrm-
3XFLAG purified from yeast reveals that Mtrm is at least partially similar the 
same analysis of Mtrm purified from ovarian lysates.  Taken together, these data 
ultimately help to validate our Y2H studies and support the view that the Y2H 
interaction between Mtrm and Polo likely reflects a direct, physical interaction. 
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2.7 Materials and Methods 
Plasmid Construction 
 For construction of Y2H plasmids, mtrm cDNA was amplified with ExTaq 
DNA Polymerase using primers 5’-cgggatccgaatggagaattctc-3’ and 5’-
tccctcgagttaaagagtgtggagcac-3’.  The PCR reaction steps included an initial 
denaturation step (94°C for 2 min), followed by 30 synthesis cycles (94°C for 30 
sec, 65°C for 45 sec, and 72°C for 2 min), and a final 10-min extension step at 
72°C.  The PCR fragment was then purified before and after co-digestion with 
BamHI and XhoI using the QIAGEN QIAquick PCR Purification Kit.  The purified, 
digested fragment was then subcloned into the pGADT7 gel purified (QIAGEN 
QIAquick Gel Extraction Kit) vector digested with the same enzymes.  polo cDNA 
was amplified with primers 5’-cgggatcctaatggccgcgaag-3’ and 5’-
tccctcgagttatgtgaacatcttctc-3’ using the PCR settings described above.  The PCR 
fragment was then purified before and after co-digestion with BamHI and XhoI 
using the QIAGEN QIAquick PCR Purification Kit.  The purified, digested 
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fragment was then subcloned into the pGBKT7 gel purified (QIAGEN QIAquick 
Gel Extraction Kit) vector digested sequentially with SalI then BamHI.  (XhoI and 
SalI produce compatible cohesive ends.)  mtrm and polo sequences within their 
respective vectors were then confirmed with Sanger sequencing  (MolSeq13102 
and 13132).  (Note:  pGADT7-polo and pGBKT7-mtrm were also generated using 
similar strategies, however, expression of pGBKT7-mtrm within the Y2H system 
exhibited a significant amount of self activation with the pGADT7 vector alone.) 
 For construction of an integrating plasmid for inducible expression of mtrm 
in yeast using the GAL1 promoter, mtrm-3XFLAG template was amplified with 
ExTaq Polymerase using primers 5’-ccgctcgaggatggagaattctcgca-3’ and 5’-
tccccgcggttacttgtcatcgtcgt-3’ using the PCR method described previously.  The 
PCR fragment was then purified before and after co-digestion with XhoI  and 
SacII using the QIAGEN QIAquick PCR Purification Kit.  The purified, digested 
fragment was then subcloned into pDK20 that was gel purified (QIAGEN 
QIAquick Gel Extraction Kit) following digestion with the same enzymes, and the 
sequence of the resulting plasmid was confirmed by Sanger Sequencing.  The 
pDK20-mtrm-3XFLAG vector was then linearized with StuI for subsequent 
transformation into the URA3 locus 
Generation of site directed mutants 
Mutations in pGADT7-mtrm and pGBKT7-polo were made using the Quik 
Change II XL Site-Directed Mutagenesis Kit (Stratagene, CA).  Changes were 
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made according to the codon preferences of S. cerevisiae.  DNA fragments 
containing the mutations were then amplified via PCR with the primers described 
above using the PCR settings described in the Y2H section above.  The PCR 
fragments were then subcloned back into clean pGADT7 or pGBKT7 vector as 
described above.  mtrm mutant and polo mutant sequences were then re-
confirmed with Sanger sequencing. 
Yeast Transformations 
 Yeast transformations were performed according to the Jaspersen Lab 
protocol.  A 50 ml overnight culture was grown in YPD.  The following day, an 
OD600 measurement was taken.  If OD600 was greater than 1.0, cells were 
diluted back to 0.1 and allowed to grow for an additional 4-6 hrs.  If OD600 was 
0.2-1.0, cells were used immediately or diluted for use later in the day.  If OD600 
was less than 0.2, cells were allowed to grow for an additional amount of time.  
At the appropriate cell density, cells were centrifuged in a 50 ml conical for 3 min 
at approximately 1500xg.  Following removal of the media, the pellet was then 
washed/resuspended in 5 ml of TE by vortexing.  Cells were then spun down, 
and following removal of the TE, cells were then washed/resuspended in 5 mL of 
LiOAc mix by vortexing.  Cells were then spun down, and following removal of 
the LiOAc, pellet was resuspended in .5 – 1 ml of LiOAc mix.  In a 1.5 ml 
microfuge tube, 100 µl cells in LiOAc mix, 10 µl freshly boiled salmon sperm, and 
1-5 ug of plasmid DNA in H2O was combined.  700 µl of PEG mix was then 
added and mix was resuspended in the microfuge tube by vortexing.  The mix 
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was subsequently incubated for 30 min at room temperature.  48 µl of DMSO 
was added followed by a brief vortex, and the mix was then incubated for 15 min 
at 42°C.  Mix was then centrifuged at 5K in a microcentrifuge and gently 
resuspended in 200-500 µl YPD.  Transformed cells were then plated on 
appropriate selective plates and grown up for 2 days at 30°C.  Note:  It is 
important to simultaneously perform a negative transformation control in which 
no plasmid DNA is added.  Secondly, 2-micron, Cen-based plasmids and PCR 
products can be directly transformed; integrating plasmids must be cut with a 
restriction enzyme to target them for integration into the yeast genome. 
Yeast Two-hybrid analysis 
Yeast two-hybrid assays were performed using the Matchmaker two-hybrid 
system 3 (Clontech).  pGADT7-mtrm and various pGADT7-mtrm mutants were 
transformed into yeast strain AH109.  pGBKT7-polo and various pGBKT7-polo 
mutants were transformed into yeast strain Y187 (Clontech).  The transformed 
strains were mated on YPD overnight, and diploids containing both constructs 
were then selected on SD plates lacking tryptophan and leucine.  These were 
then spotted at 10-fold serial dilutions on the same plates and also on reporter 
plates lacking histidine and cultured for 4 days at 30°C.  
Co-immunoprecipitations 
Two 50 ml starter cultures in YP media supplemented with 2% raffinose 
(YP-raffinose) were inoculated with colonies of freshly-streaked a WT yeast 
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strain (SLJ001) transformed with pDK20-mtrm-3XFLAG vector and a Myc3-
CDC5 strain (SLJ917) transformed with pDK20-mtrm-3XFLAG vector.  The 
inoculations were grown overnight at 30°C in a shaking incubator. Culture size 
was expanded to 100ml by dilution with YP-raffinose to an OD600 of 0.25 before 
incubation at 30°C.  When the culture reached OD600 of 0.8, the two 100ml 
cultures were divided in half.  For each genotype, 50ml cultures were induced for 
3 hrs at 30°C by the addition of galactose to a final concentration of 2%.  The 
remaining 50ml of each genotype were grown for 3 hrs at 30°C in the presence 
of 2% dextrose as our uninduced control.  Following the induction period, the four 
50ml cultures each divided into half, making eight 25ml cultures, which were then 
harvested by centrifugation (10 min, ~5,000xg, 4°C).  Pellets were snap-frozen in 
liquid nitrogen and stored at -80°C prior to co-immunoprecipitations.   
Lysates of the eight samples were prepared by bead beating at 4°C in 
500µl yeast lysis buffer followed by centrufugation at 14,000RPM for 10 min at 
4°C.  For each genotype and induction type, FLAG immunoaffinity purification 
and Myc immunoaffinity purification was performed in parallel.   
Western Analysis 
Standard techniques were used for Western analysis. The primary 
antibodies used were mouse anti-FLAG M2 (Sigma) at a dilution of 1:2000 and 
rabbit anti-Myc A14 at a dilution of 1:1000.  Immunoreactivity was detected using 
an alkaline phosphatase-conjugated mouse and rabbit secondary antibody 
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(Jackson ImmunoResearch) and the nitroblue tetrazolium and 5-bromo-4-chloro-
3-indolyl phosphatase (NBT/BCIP, Invitrogen) reagents. 
Purification of FLAG-epitope-tagged proteins and associated proteins from 
S. cerevisiae 
50ml starter cultures in YP media supplemented with 2% raffinose (YP-
raffinose) were inoculated with colonies of freshly-streaked a Myc3-CDC5 strain 
(SLJ917) transformed with pDK20-mtrm-3XFLAG vector.  The inoculations were 
grown overnight at 30°C in a shaking incubator. Culture size was expanded to 6 
Liters total by dilution with YP-raffinose to an OD600 of 0.25 before incubation at 
30°C.  When the culture turbidity reached OD600 of 0.8, 3 Liters were induced for 
3 hrs at 30°C by the addition of galactose to a final concentration of 2%.  The 
remaining 3 Liters were grown for 3 hrs at 30°C in the presence of 2% dextrose 
to serve as our uninduced control.  Following the induction period, the cultures 
were then harvested by centrifugation (10 min, ~5,000xg, 4°C).  Pellets were 
snap-frozen in liquid nitrogen and stored at -80°C prior to FLAG purification.   
FLAG purification was performed according to the specifications available 
online from the laboratory of Toshi Tsukiyama of the Fred Hutchinson Cancer 
Research Center. 
MudPIT analysis  
 MudPIT analysis is described in the Materials and Methods section of 
Chapter 3. 
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Post-translational modification analysis 
Post-translational modification analysis in conjunction with the Stowers 
proteomics core facility was performed according to the specifications previously 
described in [60]. 
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Chapter 3.  Analysis of physical interaction between 
Mtrm and Polo kinase during Drosophila female meiosis 
3.1 Introduction 
The results of the Y2H assays presented us with the intriguing finding that 
Mtrm may interact with Polo via a mechanism that does not solely depend on a 
canonical PBD binding motif.  Thus, we returned to the fly as a model to 
determine whether these findings would hold true in the native organism. In order 
to achieve this, we took advantage of φC31 site-specific Drosophila transgenic 
techniques to create a large series of 3XFLAG-mtrm mutant transgenic flies that 
are used throughout the remainder of this thesis [86].  Targeted integration is 
advantageous when comparing multiple transgenic lines.  Since our transgenes 
of interest are integrated into the same site in the Drosophila genome, positional 
effects can be mitigated.  Consistent with this view, we observed no gross 
differences in protein levels between the mtrm transgenes assayed by MudPIT 
analysis. 
 As highlighted before, MtrmS48 and MtrmS52 are reproducibly 
phosphorylated in flies, suggesting that those residues may also hold functional 
significance [60].  In addition, MtrmT40 is critical for Mtrm function during female 
meiosis as well as physical interaction with Polo kinase as assayed by co-
immunoprecipitations from ovarian lysates [60].  Consistent with this view, the 
Y2H studies described in Chapter 2 demonstrate that MtrmS48 and Mtrm52 are 
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critical for physical interaction with Polo.  However, these studies proved 
contradictory for MtrmT40.  Unlike the studies in the fly, Y2H analysis suggested 
that MtrmT40 is dispensable for physical interaction with Polo.  In order to 
address this, we performed MudPIT mass spectrometry on 3XFLAG-epitope-
tagged versions of Mtrm purified from ovarian lysates.  These tagged Mtrm 
mutants containing either single alanine substitutions targeting conserved 
residues or N or C-terminal truncations of Mtrm.  MudPIT analysis allows not only 
for us to examine the ability of a particular Mtrm mutant interact with endogenous 
Polo, but also to identify other Mtrm interactors that could potentially play a role 
in the Mtrm-Polo interaction. 
3.2 MudPIT analysis of Flag-tagged Mtrm purified from 
ovarian lysates 
MudPIT mass spectrometry is a highly sophisticated technique that allows 
for the analysis of complex protein mixtures.  The advantages over traditional 
mass spectrometry techniques are significant.  By coupling high-pressure liquid 
chromatography and tandem mass spectrometry with sophisticated database 
software and automated data collection systems, the technique allows for a more 
unbiased proteomic analysis with a high degree of sensitivity allowing for the 
identification of both high and low abundance proteins.   
The relative abundance of a given protein in the sample is best 
approximated by its normalized spectral abundance factor (NSAF) [87], which 
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may be calculated by the following equation, where SpC is spectral count and L 
is protein length: 
                               
 
In short, NSAFs are an estimate of protein abundance (SpC) adjusted for protein 
length (L) and the percentage of total spectra within a given run.  Statistical 
analysis of runs from multiple biological replicates of data is made possible by 
Power Law Global Error Model (PLGEM) software [88], which calculates signal to 
noise (STN) ratios of NSAF datasets allowing us to identify differentially 
abundant proteins across samples. 
As defined by NSAF, abundances of proteins from ovarian lysates that co-
purify with 3XFLAG-Mtrm, 3XFLAG-MtrmT40A, 3XFLAG-MtrmS48A, 3XFLAG- 
MtrmSTPDEL and 3XFLAG-MtrmSAMDEL were compared to their levels in a set 
of negative control samples (w1118 ovaries) that were also affinity purified.  We 
then performed PLGEM analysis, we subsequently evaluated datasets of 
proteins selected by two relative NSAF p-value thresholds: p ≤ 0.001 (Table 3.1) 
and ≤ 0.005 (Table 3.2). 
 As shown in Table 3.1, only five proteins co-purified with full-length 
3XFLAG-Mtrm that filled the most stringent criteria of having a p-value ≤ 0.001: 
Polo kinase, vitilline membrane 26Aa, heat shock protein 26, heat shock protein 
27 and heat shock protein 23.  Moreover, Mtrm mutants 3XFLAG-MtrmT40A, 
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3XFLAG-MtrmS48A, 3XFLAG-MtrmSTPDEL, and 3XFLAG-MtrmSAMDE failed 
to co-purify Polo at the same level of significance.  These results are congruent 
with our Y2H findings with the exception of the MtrmT40A result.  In the fly, 
MtrmT40 is critical for physical interaction with endogenous Polo as assayed by 
MudPIT analysis.  In addition, the data regarding MtrmT40A are consistent with 
previously published work [60].   
The example of vitelline membrane 26Aa being called a Mtrm ‘interactor’ 
demonstrates one of the pitfalls in simply using p-values calculated by PLGEM 
for candidate selection.  PLGEM evaluates how two data sets differ from each 
other:  in this case the seven NSAF values for vitelline membrane 26Aa in the 
seven experimental runs (NSAF = {0, 0.0004, 0.0003, 0, 0, 0.0004, 0.1336}) 
versus the five in the control samples (NSAF = {0, 0.0010, 0, 0, 0}).  Clearly, the 
exceedingly high, outlying NSAF in one Mtrm MudPIT run artifactually shifted the 
rank of vitelline membrane 26Aa from a non-significant to one of significance. By 
contrast, we may be more confident in stating that Mtrm and Polo interact due to 
a more consistent NSAF set with higher values from the experimental duplicates 
(NSAF = {0.0147, 0.009, 0.005, 0.0140, 0.0117, 0.0259}).  Until a better 
algorithm is developed, compiling protein lists and determining potential binding 
partners will require not only filtering by p-value, but also manual assessment. 
 
 
 
 
 53 
Table 3-2 lists those interactors that were detected at significant levels 
when the p-value threshold was then increased to p ≤ .005 (including the 
previously presented proteins listed at a threshold of p ≤ 0.001).  The putative 
binding partners of Mtrm or Mtrm mutants may shed light on the possible 
functions of specific Mtrm residues and domains as well as perhaps yet to be 
discovered roles that the Mtrm-Polo complex may play during Drosophila female 
meiosis.  Intriguing interactors of the full length 3XFLAG-Mtrm include Dodo, 
Lodestar, Cdc2c, Belle, and Cdc16.  Interestingly, Dodo is the Drosophila 
homologue of human PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 
1), which is phosphorylated by human Plk1 [89].  Interestingly, PIN1 selectively 
 
Table 3-1 Protein co-purified with 3XFLAG-Mtrm and 3XFLAGMtrm mutant proteins with 
statistical significance of p ≤ 0.001. 
Ovarian lysates were made from 100 ovaries dissected from the Drosophila females expressing the 
version of 3XFLAG-epitope tagged Mtrm and subjected to immunoaffinity purification and MudPIT 
mass spectrometry. Relative abundance of proteins as described by the NSAF were calculated by 
NSAF7, and statistical significance (p-value) of a protein’s NSAF for multiple MudPIT runs relative to 
a No-FLAG negative control was evaluated by PLGEM (Mtrm, n=7; Mtrm-T40A, n=4; Mtrm-S48A, 
n= 7; MtrmSTPDEL, n=2; MtrmSAMDEL, n=2; Control, n=5). The table shows a list of proteins 
(highlighted yellow) found in addition to Mtrm, MtrmT40A, MtrmS40A, MtrmSTPDEL, or 
MtrmSAMDEL that were detected at significant levels when the p-value threshold was set to p ≤ 
0.001. 
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targets phosphorylated pS/pT-P motifs in order to facilitate the regulation of the 
phosphorylation state (among other post-translational modifications) of its 
substrates.  Other proteins listed as significant when the threshold is set to p ≤ 
0.005 include several members of the Anaphase-Promoting Complex/Cyclosome 
(APC/C) complex:  Cdc16, Cdc23, Shattered, and Imaginal discs arrested.  The 
APC/C is an E3 ubiquitin ligase that is known for targeting cell cycle proteins for 
degredation by the proteasome.  Indeed, these data may make biological sense 
as the current hypothesis holds that Mtrm is rapidly degraded upon or shortly 
after NEB.   
Interestingly, the truncated version of Mtrm lacking its C-terminal SAM 
domain (MtrmSAMDEL) loses a vast number of protein associations.  This result 
supports the view that a primary role of the SAM domain of Mtrm is to mediate 
protein-protein interactions.  Curiously, the STP deletion of Mtrm (MtrmSTPDEL) 
appears to interact with an increased number of protein partners with a p value ≤ 
.005.  From these data, we speculate that the C-terminal SAM domain of Mtrm 
may function as the primary domain for protein-protein interactions while the STP 
region may facilitate specificity of binding.  The few proteins that do co-purify with 
MtrmSTPDEL with a p value of ≤ .005 appear to be associated with 
ubiquitination: CG10254, isoform B; cdc16; skpA; elongin C; hyperplastic discs; 
the NUB1 homolog; Apc 1, 5, and 8.  From this data alone, it is not entirely clear 
whether Mtrm-STPDEL is involved in the ubiquitin-degradation pathway or is 
simply in the process of being degraded itself. 
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Table 3-2 Protein co-purified with 3XFLAG-Mtrm and 3XFLAG-Mtrm mutant proteins with 
statistical significance of p ≤ 0.005. 
Ovarian lysates were made from 100 ovaries dissected from the Drosophila females expressing 
the version of 3XFLAG-epitope tagged Mtrm and subjected to immunoaffinity purification and 
MudPIT mass spectrometry. Relative abundance of proteins as described by the NSAF were 
calculated by NSAF7, and statistical significance (p-value) of a protein’s NSAF for multiple 
MudPIT runs relative to a Flag-only negative control was evaluated by PLGEM (Mtrm, n=7; Mtrm-
T40A, n=4; Mtrm-S48A, n= 7; MtrmSTPDEL, n=2; MtrmSAMDEL, n=2; Control, n=5). The table 
shows a list of proteins (highlighted yellow) found in addition to Mtrm, -T40A, -S40A, STPDEL, or 
SAMDEL that were detected at significant levels when the p-value threshold was set to p ≤ 
0.005.  
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Table 3-2 (cont.) 
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Table 3-2 (cont.) 
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3.3 Relative abundance ratios of Polo versus various Mtrm 
mutants 
The sensitivity of MudPIT analysis provides a means by which to quantitate 
how interactions between Mtrm and Polo are affected by mutation. We compared 
average NSAF values of the two proteins across a series of Mtrm mutations – 
MtrmSTPDEL, MtrmSAMDEL, MtrmS39A, MtrmT40A, MtrmF46A, MtrmS48A, 
MtrmS52A, and MtrmS137A –the results of which are summarized in Figure 3.1. 
All Mtrm mutants studied appeared to affect interaction with Polo, albeit to 
varying degrees. Both the N and C-terminal truncations of Mtrm greatly disrupted 
Mtrm-Polo interaction as did alanine substitution of MtrmT40, MtrmS48, and 
MtrmS52.  By contrast, substitution of MtrmS39 and MtrmF46, and MtrmS137 
with alanine allowed partial binding.  These findings are worthy of note, and their 
significance will be discussed in relation to results of the Drosophila genetic 
studies described in Chapters 4 and 5.  
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Figure 3-1 Average Polo versus Mtrm/Mtrm mutant NSAF Ratios.  
Ovarian lysates were made from 100 ovaries dissected from the Drosophila females expressing the 
version of 3XFLAG-epitope tagged Mtrm and subjected to immunoaffinity purification and MudPIT mass 
spectrometry. Relative abundance of proteins as described by the NSAF were calculated by NSAF7. 
Bars represent the average Polo:Mtrm NSAF ratio, which is also summarize in the adjoining table.  
Points represent the distribution of NSAF ratios over n samples.  
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3.4 Discussion 
This chapter describes the most detailed biochemical analysis of the 
Mtrm:Polo interaction to date. Strikingly, the results confirm much of what was 
observed in the Y2H analysis of Mtrm mutants and also address the incongruent 
finding regarding interaction between MtrmT40A and Polo predicted by Y2H. 
In addition, we present proteomic analysis of additional potential Mtrm-
interacting proteins.  While the PLGEM algorithm provides an unbiased 
evaluation of MudPIT datasets, it is clear that more work is required to design a 
computational method to filter data. Regardless, our efforts have yielded a 
number of candidate proteins that may be studied in the context of Drosophila 
female meiosis. 
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3.6 Materials and Methods 
Generation of site-directed mutants 
Mutations in the mtrm gene were generated using the Quik Change II XL 
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Site-Directed mutagenesis Kit (Stratagene, CA) in conjunction with the Stowers 
molecular biology core facility.  A 3.1 kb ScaI fragment containing the mtrm gene 
flanked by its regulatory elements derived from the Bac clone BACR13D12 was 
isolated via gel purification and sequentially subjected to enzymatic digestion and 
then subcloned into pBS-KSII+ (Clonetech, CA), which was then used for site 
directed mutagenesis. (The 3.1 kb fragment was used so that genomic mutant 
versions of mtrm could be easily generated in the future if desired.)  The resultant 
pBS-mtrm containing the engineered mutation was then utilized as the PCR 
template for generating the transgene to be integrated in the fly as described in 
the below.  All mutational changes were specifically designed to comply with D. 
melanogaster codon usage bias. 
Generation of fly transgenes  
A single strategy was employed for the generation of all 3XFLAG-mtrm 
mutant transgenes used in Chapters 3, 4 and 5.  All mtrm PCR products were 
amplified by the primers listed below.  The resulting products were digested with 
NotI and BamHI and then subcloned into the pUASp-attB-5’FLAG vector (gift 
from S. Takeo) digested with the same enzymes. Following verification with 
Sanger sequencing.  
Both the full length and alanine substitution versions of the mtrm gene 
were amplified via PCR with primers 5’-cggcggccgcatggagaattctcgcacgc -3’ and 
5’-cggggatccttaaagagtgtggagcacatccatg -3.’ The N-terminal mtrm truncation 
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deleting the first 53 amino acids of Mtrm was amplified from full length mtrm with 
primers 5’- cggcggccgcatgcccatcgagaatatgggcacg -3’ and 5’-
cggggatccttaaagagtgtggagcacatccatg-3.  The C-terminal mtrm truncation deleting 
the last 64 amino acids of Mtrm was amplified from full length mtrm with primers 
5’- cggcggccgcatggagaattctcgcacgc -3’ and 5’- gccggatccttacgagtggttcgatgc -3. 
φC31 site-specific integration into the Drosophila genome 
φC31 site-specific integration was utilized to introduce the fly transgenes 
into the D. melanogaster genome. This system uses φC31 integrase, which 
mediates recombination between the bacterial and phage attachment sites, attB 
and attP. Expression of φC31 integrase allows for efficient integration of attB-
containing plasmids including the transgene of interest into attP loci that have 
been previously inserted into the D. melanogaster genome. For this work, we 
used the attP40 D. melanogaster line for insertion on Chromosome 2 [86]. 
Because all fly transgenes are inserted into the same locus, any positional 
effects that would otherwise result via traditional transgenesis techniques are 
mitigated, thus allowing for a comparative analysis between transgenes. Embryo 
injection of pUASp-attB-5’FLAGmtrm DNAs into attP40 embryos expressing 
φC31 integrase were performed by Genetic Services, Inc. 
Immunoprecipitation of FLAG-epitope tagged proteins from Drosophila 
ovarian lysates 
Ovaries from approximately 100 Drosophila females per FLAG IP were 
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dissected in 1X PBS and homogenized with an IP buffer (50 mM Tris-HCl pH 6.8, 
150 mM NaCl, 2.5mM EGTA, 2.5mM EDTA, 0.1% Triton X-100, 1 mM protease 
inhibitor cocktails). Lysates were cleared by centrifugation twice at 14,000 rpm 
for 15 min at 4°C. Lysates were added to 100 µl of equilibrated EZview Red 
ANTI-FLAG M2 Affinity 5 hrs at 4°C. The beads were washed with cold IP buffer 
5 times for 10 min each at 4°C. Proteins were eluted with 100 µl of 200 ng/µl 
3XFLAG peptide in TBS pH 7.4 by incubating for 1 hr at 4°C on a rocker. After 
collecting the supernatant, proteins were eluted again with another 100 µl of 200 
ng/µl 3XFLAG peptide. 5µl (or 95%) of both elution 1 and 2 were run on SDS-
PAGE (4-12% NuPAGE gradient gel) and silver-stained (Invitrogen, 
SilverExpress) The remainder of the eluates were then TCA-precipitated.  
TCA precipitation of eluates 
Each sample was brought to 400 µl with 100 mM Tris-HCL, pH 8.5. 100 µl 
TCA (final concentration of 20%) was added, and the reactions were carried out 
o/n at 4°C. The samples were then spun down at 14,000 rpm 30 min at 4°C, 
pellets were washed with cold acetone and spun at 14,000 rpm 10 min at 4°C 
twice. Pellets were subsequently air dried and submitted to the Stowers 
proteomics core facility as a dried pellet. 
MudPIT analysis of proteins purified from Drosophila ovarian lysates 
MudPIT analysis was performed in collaboration with the Stowers 
proteomics core facility. TCA-precipitated proteins were resuspended in 30 µl of 
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100 mM Tris-HCl, pH 8.5, 8 M urea, reduced with 5 mM TCEP (Tris(2-
Carboxylethyl)-Phosphine Hydrochloride, Pierce), and alkylated with 10 mM CAM 
(Chloroacetamide, Sigma). Endoproteinase Lys-C (Roche) was added to a final 
concentration of 0.1 ug/µl for at least 6 hours at 37°C; then the sample was 
diluted to 2 M urea with 100 mM Tris-HCl, pH 8.5. Calcium chloride was added to 
a final concentration of 2 mM, and the digestion with trypsin (0.1 ug/µl) was let to 
proceed overnight at 37°C while shaking.  The reaction was quenched by adding 
formic acid to 5% and the peptide mixture was loaded onto a 100 µm fused silica 
microcapillary column packed with 8 cm of reverse phase material (Aqua, 
Phenomenex), followed by 3 cm of 5-µm Strong Cation Exchange material 
(Partisphere SCX, Whatman) and 2 cm of 5-µm C18 reverse phase. 
The loaded microcapillary column was placed in-line with a Quaternary 
Agilent 1100 series HPLC pump.  Overflow tubing was used to decrease the flow 
rate from 0.1 ml/min to about 200–300 nl/min.  Fully automated 10-step 
chromatography runs were carried out.  Three different elution buffers were used: 
5% acetonitrile, 0.1% formic acid (Buffer A); 80% acetonitrile, 0.1% formic acid 
(Buffer B); and 0.5 M ammonium acetate, 5% acetonitrile, 0.1% formic acid 
(Buffer C).  Peptides were sequentially eluted from the SCX resin to the reverse 
phase resin by increasing salt steps, followed by an organic gradient.  The last 
two chromatography steps consisted in a high salt wash with 100% Buffer C 
followed by the acetonitrile gradient.  The application of a 2.5 kV distal voltage 
electrosprayed the eluting peptides directly into a LTQ ion trap mass 
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spectrometer equipped with a nano-LC electrospray ionization source 
(ThermoFinnigan).  Full MS spectra were recorded on the peptides over a 400 to 
1,600 m/z range, followed by three tandem mass (MS/MS) events sequentially 
generated in a data-dependent manner on the first, second, and third most 
intense ions selected from the full MS spectrum (at 35% collision energy).  Mass 
spectrometer scan functions and HPLC solvent gradients were controlled by the 
Xcalibur data system (ThermoFinnigan).   
SEQUEST was used to match MS/MS spectra to peptides in a database of 
37016 sequences, consisting of 18331 Drosophila melanogaster proteins 
(downloaded from NCBI on 2009-12-23), 177 usual contaminants such as human 
keratins, IgGs, and proteolytic enzymes.  To estimate false discovery rates 
(FDR), each protein sequence was randomized (keeping the same amino acid 
composition and length) and the resulting 18508 "shuffled" sequences were 
added to the database used for the SEQUEST searches.  The validity of 
peptide/spectrum matches was assessed using the SEQUEST-defined 
parameters, cross-correlation score (XCorr) and normalized difference in cross-
correlation scores (DeltCn).  Spectra/peptide matches were only retained if they 
had a DeltCn of at least 0.08 and,minimum XCorr of 1.8 for singly-, 2.5 for 
doubly-, and 3.5 for triply-charged spectra.  In addition, the peptides had to be 
fully-tryptic and at least 7 amino acids long.  Combining all runs, proteins had to 
be detected by at least 2 such peptides, or 1 peptide with 2 independent spectra. 
Under these criteria the final FDRs at the protein and peptide levels were % ± 
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and % ± , respectively.  DTASelect was used to select and sort peptide/spectrum 
matches passing this criteria set.  Peptide hits from multiple runs were compared 
using CONTRAST.  To estimate relative protein levels, spectral counts were 
normalized; using an in-house developed script (NSAF7): for each protein k 
detected in a particular MudPIT analysis, Normalized Spectral Abundance 
Factors (NSAFs) were calculated as shown in the chapter. 
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Chapter 4.  Residues and regions of Mtrm critical for 
proper homologous achiasmate segregation 
4.1 Introduction 
As discussed in Chapter 1, mtrm is critical for homologous achiasmate 
segregation—a well characterized process in Drosophila that ensures the faithful 
segregation of chromosome pairs that do not recombine during female meiosis.  
Females heterozygous for a null allele of mtrm display high levels of achiasmate 
chromosome nondisjunction (NDJ).  Importantly, this phenotype is genetically 
linked to polo as the high levels of achiasmate chromosome NDJ can be fully 
suppressed by simultaneous reduction of the polo gene [60].  As mentioned 
previously, mutating the central residue of the Polo-box domain (PBD) binding 
motif, MtrmT40, to alanine ablates both the physical interaction of Mtrm with Polo 
and Mtrm’s function as assayed by homologous achiasmate segregation [60].  
Thus, we hypothesized that Mtrm negatively regulates Polo during Drosophila 
female meiosis via physical interaction. As outlined in Chapter 2, our Y2H data 
suggest that the physical interaction is direct.  Moreover, analysis in both the fly 
and in yeast (Chapters 2 and 3) suggest that physical interaction between these 
two proteins does not solely depend on the PBD binding motif.  Several 
additional residues/regions within Mtrm, such as the C-terminal SAM domain and 
conserved phosphorylation sites including MtrmS48 and MtrmS52 appear to be 
important for its physcial association with Polo. 
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This chapter tests the hypothesis of whether additional Mtrm 
residues/regions critical for physical interaction with Polo are also critical for Mtrm 
function as assayed by homologous achiasmate segregation during Drosophila 
female meiosis.  We first independently verify the genetic interaction between 
mtrm and polo as it relates to homologous achiasmate segregation.  We then 
take advantage of mtrm homolog sequences representing 30 million years of 
divergence by testing their ability to rescue the homologous achiasmate 
segregation defects observed in Drosophila females heterozygous for a null 
allele of mtrm.  These results allowed us to narrow our focus to three blocks of 
conserved sequence within the mtrm gene.  In addition to truncation analysis, we 
also performed an alanine-scanning mutagenesis of those conserved residues in 
an effort to identify additional specific mutations in Mtrm that are required for 
homologous achiasmate segregation.   
4.2 Co-suppression of defect using multiple mutant alleles of 
mtrm and polo 
The work described by Xiang et al. in 2007 primarily used a null allele of 
mtrm (mtrm126) made by imprecise excision of the P element insertion KG08051, 
which deletes 80 bp upstream of the start codon in mtrm and 123 bp downstream 
of the mtrm start codon [60].  Using this allele, Xiang et al. demonstrated that 
females heterozygous for mtrm126 displayed high levels of achiasmate NDJ as 
assayed by FM7/X and fourth chromosome segregation.  (As mentioned in 
Chapter 1, FM7 is a balancer chromosome that fully suppresses recombination 
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between the Xs, and the fourth chromosomes of Drosophila females are always 
achiasmate.)  Xiang et al. also demonstrated that this phenotype is fully 
suppressed by simultaneous reduction of the polo gene by using several mutant 
alleles of polo including the P element insertion site mutants poloKG03033 and 
polo16-1 and a deficiency that uncovers the polo gene (Df(3L)rdgC-co2) [60].   
We confirmed these results by testing whether the NDJ phenotype of an 
independently derived deficiency that uncovers the mtrm gene (Df(3L)66C-T2-
T10) could be suppressed by simultaneous reduction of the polo gene using the 
poloKG03033 and polo16-1 mutants.  We found that FM7/X females heterozygous for 
Df(3L)66C-T2-T10 displayed a high level of achiasmate NDJ:  approximately 
23% and 15% X and fourth chromosome NDJ respectively, which is consistent 
with previously published work utilizing this particular deficiency allele [59].  
Reduction of the polo function using either poloKG03033 or polo16-1 greatly 
suppressed this phenotype.  Females trans-heterozygous for Df(3L)66C-T2-T10 
and poloKG03033  exhibited approximately 1% and .5% X and fourth achiasmate 
NDJ respectively, and females trans-heterozygous for Df(3L)66C-T2-T10 and 
polo16-1 exhibited approximately 0% and .5% X and fourth achiasmate NDJ 
(Table 4-1).  Taken together, these results confirm that mtrm and polo genetically 
interact, and their function is required to ensure proper segregation of 
achiasmate chromosomes. 
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Table 4-1  Detailed segregational effects of simultaneous heterozygosity for a deficiency 
that uncovers mtrm and two mutant alleles of polo. 
FM7/X; spapol females containing a deficiency that uncovers mtrm (Df(3L)66C-T2-T10) exhibit 
levels of achiasmate X and fourth chromosome NDJ consistent with previously published work 
[59].  When females of this genotype are also heterozygous for poloKG03033 or polo16-1, the levels of 
NDJ are greatly reduced.  These co-suppression results are consistent with previously published 
work [60], and confirm using an independently derived null allele of mtrm that mtrm and polo 
genetically interact to govern homologous achiasmate segregation.   
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4.3 Evolutionarily conserved residues are critical for proper 
homologous achiasmate segregation 
As described in Chapter 1 and shown in Figure 1-3, mtrm is conserved 
throughout the genus Drosophila.  A sequence alignment of the predicted Mtrm 
protein from 12 sequenced Drosophila species revealed three highly conserved 
blocks of sequence. One block surrounds an S-T40-P sequence that fits a 
canonical PBD consensus motif, one is located just proximal to the C-terminal 
sterile alpha SAM domain of Mtrm.  In addition, critical residues within the SAM 
domain are also evolutionarily conserved.  Aside from these domains, the 
sequence of Mtrm in the Drosophila species is quite divergent, with 38.6% 
identity between Mtrm of D. melanogaster Mtrm and D. grimshawi Mtrm (see 
Figure 4-1 for phylogram of sequenced Drosophila species.)  Because of this 
divergence, it was not clear if the evolutionarily divergent mtrm homologs would 
be able to rescue the meiotic defects observed in D. melanogaster females 
heterozygous for a null allele of mtrm.  Such a finding would be beneficial, 
however, because it would allow us to narrow our focus to those residues that 
are evolutionarily conserved. 
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In order to determine the functionality of various mtrm homologs in a D. 
melanogaster host, constructs containing various mtrm homologs N-terminally 
tagged with 3XFLAG were integrated into the Drosophila genome at the attP40 
site and expressed in the germline using the nanos-GAL4 driver.  As a control, 
we expressed D. melanogaster mtrm tagged in an identical manner, integrated at 
the same site and driven by the nanos-Gal4 promoter.  The transgenes were 
crossed into an FM7/X genetic background also containing one copy of a 
           
 
Figure 4-1  Phylogram of 12 sequenced species of Drosophila. 
mtrm homologs are identified in 12 sequenced species of Drosophila.  In addition to D. 
melanogaster mtrm, D. pseudoobscura, D virilis, D. mojavensis and D. grimshawi mtrm (yellow 
asterisks) were all functional when expressed in a D. melanogaster host.  These results allow 
us to narrow our focus on those Mtrm residues/regions that have been conserved for 
approximately 30 million years. 
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recombinant third chromosome containing both the nanos-GAL4 driver and the 
mtrm126 null mtrm allele.   
 As shown in Table 4-2, expression of wild type D. melanogaster mtrm 
fully rescues the homologous achiasmate segregation defects observed in mtrm 
null heterozygotes, indicating that the transgene driven by the nanos-Gal4 driver 
is functional as assayed by homologous achiasmate segregation.  Importantly, 
we found that D. pseudoobscura mtrm, D. virilis mtrm, D. mojavensis mtrm and 
D. grimshawi mtrm are all able to rescue the homologous achiasmate 
segregation defects to levels comparable to D. melanogaster mtrm when 
expressed in the FM7/X; nanos-Gal4-mtrm126 mutant females.  The fact that 
even the most divergent homolog, D. grimsahwi mtrm, is functional in D. 
melanogaster suggests that the functionally significant areas of sequence 
sufficient to ensure proper chromosome segretaion (and perhaps control of Polo) 
are likely to involve those that are evolutionarily conserved—the STP region, a 
short region just proximal to the SAM domain, and/or the SAM domain itself.  
 
 
Table 4-2  Detailed segregational effects of various mtrm homologs in Drosophila 
species. 
FM7/X; spapol females also containing a recombinant third chromosome with both the 
nanos-GAL4 driver and the mtrm126 allele exhibit high levels of achiasmate X and fourth 
chromosome NDJ consistent with previously published work [60].  Females expressing 
various mtrm homologs in this genetic background were all able to rescue the observed 
homologous achiasmate segregation defects, indicating that those Mtrm residues that are 
functionally important are also those that have been evolutionarily conserved. 
a Transgenes expressed in a FM7/X; nanos-GAL4-mtrm126/+; spapol background  
 
 
 74  
 
 
 75 
4.4 Truncation analysis:  the SAM domain of Mtrm appears 
dispensable for homologous achiasmate segregation 
In Chapter 3, we demonstrated that both the N-terminal region and the C-
terminal SAM domain of Mtrm are critical for the physical interaction with Polo 
that is robust enough to be detected by immunoaffinity purifications and 
subsequent MudPIT analysis.  We also wanted to examine whether these 
regions of Mtrm were required for Mtrm function as assayed by homologous 
achiasmate segregation (below) and oocyte development (discussed in Chapter 
5).  
Using the same strategy for integration and expression, we introduced 
truncated versions of mtrm into FM7/X females also heterozygous for nanos-
Gal4-mtrm126.  The N-terminal deletion, MtrmSTPDEL, deleting amino acids 2 – 
53 of Mtrm (including the conserved S-T40-P sequence) was not able to rescue 
the meiotic defect (Table 4-3).  Compared to control females heterozygous for a 
null allele of mtrm with no rescue construct, which displayed approximately 50% 
and 40% achiasmate X and fourth chromosome NDJ respectively, females 
expressing the MtrmSTPDEL truncation in this genetic background displayed 
approximately 38% and 28% X and fourth chromosome NDJ respectively.  These 
results are not surprising, as previous work has demonstrated that MtrmT40 is 
critical for Mtrm function as assayed by homologous achiasmate segregation 
[60]—a truncated version of Mtrm that results in the deletion of this residue would 
not be expected to rescue functionality in this context. 
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The C-terminal deletion, MtrmSAMDEL, which deletes the last 64 amino 
acids of the protein including the SAM domain, however, is able to complement 
the meiotic defects (Table 4-3).  Females heterozygous for a null allele of mtrm 
expressing the MtrmSAMDEL truncation displayed approximately 11% and 7% X 
and fourth chromosome NDJ respectively.  These results are quite unexpected 
since the SAM domain of Mtrm appears to be critical for robust physical 
interaction with Polo in both flies and yeast (Chapter 2 and Chapter 3).  This 
intriguing result suggests that perhaps a transient interaction exists between Polo 
and a region of Mtrm that is proximal to the SAM domain, and this transient 
interaction that goes otherwise undetected is sufficient to ensure proper 
homologous achiasmate segregation.  
A number of different reasons might account for the apparent discrepancy 
between the physical and genetic data regarding the importance of the SAM 
domain for Mtrm function.  First, our immunopurification conditions may have 
been too stringent to detect a weak or transient interaction between Polo and 
MtrmSAMDEL. Secondly, the affinity of MtrmSAMDEL for Polo may be reduced, 
which could also account for why we did not detect an association.  Alternatively, 
the ability of MtrmSAMDEL to rescue NDJ may occur through a mechanism that 
is Polo-independent.  Mtrm binds to a number of proteins in an oocyte extract, 
and alteration in binding to one of these, rather than Polo, may lead to the 
decreased rate of achiasmate NDJ.  Additional studies aimed at testing 
MtrmSAMDEL binding to Polo and other meiotic regulators will help distinguish 
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between these possibilities. 
Based on the observation that creation of a single point mutant (MtrmT40A) 
in the PBD abrogates its ability to robustly interact with Polo and its ability to 
function as assayed by homologous chromosome segregation as described in 
Chapters 2 and 3 and previously [60], even when the SAM domain is present, we 
propose that Mtrm primarily binds to Polo via the PBD binding motif and the 
surrounding region.  Consistent with this hypothesis, we identify other Mtrm point 
mutants (with an intact SAM domain) that behave similarly to MtrmT40A with 
regard to their ability to bind to Polo and to result in defects in homologous 
achiasmate segregation (see Section 4.5). Taken together with the results 
demonstrated in the previous section, Section 4.3, we hypothesize that those 
residues are likely the evolutionarily conserved motifs within Mtrm that are most 
important for its interaction with Polo during female meiosis. 
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Table 4-3  Detailed segregational effects of N and C-terminal mtrm truncations 
expressed in females heterozygous for a null allele of mtrm. 
FM7/X; spapol females containing a recombinant third chromosome with both nanos-GAL4 and 
mtrm126 expressing an N-terminally truncated version of Mtrm are not able to engage in proper 
homologous achiasmate segregation.  By contrast, females expressing a C-terminally 
truncated versionof Mtrm (MtrmSAMDEL) are able to ensure proper homologous achiasmate 
segregation.  
a Transgenes expressed in a FM7/X; nanos-GAL4-mtrm126/+; spapol background. 
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4.5 Dissecting the conserved regions proximal to the SAM 
domain of Mtrm via alanine-scanning mutagenesis 
In order to identify conserved Mtrm residues that are required for 
homologous achiasmate segregation, we performed an alanine-scanning 
mutagenesis of the two blocks of conservation proximal to the SAM domain.  
Specifically, we mutated residues within the STP region, which contains a 
canonical Polo PBD binding motif surrounded by a larger region of evolutionary 
conservation and the region of conservation just proximal to the C-terminal SAM 
domain (see Figure 1-2).   The results from our mutational analysis by Y2H in 
Chapters 2 and in vivo in the fly (Chapter 3) suggest that in addition to the 
canonical PBD binding motif, other residues within these regions of Mtrm play a 
role in its physical interaction with Polo.  Additionally, analysis of post-
translational modifications (PTM) on Mtrm demonstrated that, in addition to 
MtrmT40, MtrmS48 and MtrmS52 are phosphorylated in the fly [60].  Together, 
these observations raise the possibility that, in addition to residues falling within 
the canonical PBD binding motif (S-T40-P), other conserved residues may be 
required for Mtrm function.  
Using the same approach for assaying achiasmate NDJ as described 
above, we first examined the functional role of the S-T40-P sequence itself. As 
shown in Table 4-4, our results suggest that only the last two residues of the S-
T40-P PBD binding site are required for Mtrm function.  Expression of a 
MtrmS39A mutant disrupting the serine at the – 1 position relative to the central 
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threonine within the PBD binding motif fully rescued the meiotic defect relative to 
the Full-length (FL) Mtrm control, while expression of a MtrmT40A mutant or a 
MtrmP41A mutant were unable to rescue the meiotic defect observed in nanos-
GAL4-mtrm126/+ heterozygote females (Table 4-4).  The fact that the mutant 
MtrmS39A protein is functional with regard to homologous achiasmate 
segregation is somewhat surprising, as the serine at the – 1 position has been 
predicted to be absolutely required for interaction with the PBD [46,54].  
However, as noted in Chapter 1, cases also exist where PBD binding sites have 
been defined that lack a serine at the –1 position relative to the phosphorylatable 
residue [55].  
We expanded our analysis to include other conserved residues both within 
and surrounding the STP region.  Of the 26 amino acids we mutated to alanine 
between positions 29 and 66 (including the S-T40-P residues), 15 point mutants 
appeared to fully rescue Mtrm function relative to the FLMtrm control.  3 mutants 
appeared to partially rescue Mtrm function (MtrmV31A, MtrmV36A, and 
MtrmF46A), and 8 mutants failed to rescue functionality as assayed by 
homologous achiasmate segregation (MtrmT40A, MtrmP41A, MtrmS48A, 
MtrmP49A, MtrmL51A, MtrmS52A, MtrmP53A and MtrmI54A) (Table 4-4).   
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An additional 10 conserved residues proximal to the SAM domain were 
examined.  MtrmE141 and MtrmN151 appear to be critical for function as 
assayed by homologous achiasmate segregation (Table 4-4).  Taken together, 
these results indicate that multiple Mtrm residues appear critical for homologous 
chromosome segregation. 
 
Table 4-4  Detailed segregational effects of amino acid to alanine Mtrm mutants 
expressed in females heterozygous for a null allele of mtrm. 
FM7/X; spapol females containing a recombinant third chromosome with both nanos-GAL4 and 
mtrm126 expressing mutant versions of mtrm where conserved amino acids are individually 
mutated to alanine are tested for their ability to function as assayed by homologous achiasmate 
segregation 
a Transgenes expressed in a FM7/X; nanos-GAL4-mtrm126/+; spapol background. 
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4.6 Discussion 
The results described in this Chapter demonstrate that evolutionarily 
conserved residues appear to be sufficient for Mtrm function in the context of 
homologous achiasmate segregation.  A strong correlation appears to exist 
between the ability of different versions of Mtrm to rescue chromosome 
segregation defects and their physical interaction with Polo, which was discussed 
in Chapters 2 and 3.  Mutants able to bind Polo also rescued achiasmate NDJ, 
while mutants that failed to interact with Polo resulted in high levels of 
achiasmate NDJ.  The MtrmSAMDEL construct there is only exception to this 
correlation.  While required for robust physical interaction, MtrmSAMDEL 
appears dispensable in the context of homologous chromosome segregation.  
Therefore we propose that the interaction between Mtrm and Polo is first 
established by residues proximal to the SAM domain, which is sufficient for 
function as assayed by homologous achiasmate segregation, but that 
maintenance of this interaction must also involve the C-terminal SAM domain, 
which may be required for some other meiotic process (discussed in Chapter 5).   
The data described in this chapter suggest that the transient establishment 
of interaction between Mtrm and Polo that is required for homologous 
chromosome segregation is in part due MtrmT40 and its corresponding proline, 
MtrmS48 and its corresponding proline, and a four amino acid sequence 
spanning MtrmL51 to MtrmI54 (which includes MtrmS52 and its corresponding 
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proline).  Since MtrmT40, MtrmS48 and MtrmS52 are all phosphorylated, it 
seems likely that phosphorylation regulates binding between Mtrm and Polo.   
The identity of those kinases that phosphorylate MtrmT40A, MtrmS48A and 
MtrmS52A remains unclear, but the fact that each phosyporylatable residue is 
followed by a proline suggests the task is performed by a proline directed kinases 
such as Cdk5, Cdk1 or MAPK kinases as predicted by the NetPhosK algorithm 
[62].  Furthermore, the inability of MtrmP41A, MtrmP49A or MtrmP53A to rescue 
the defects in chromosome segregation could be interpreted in two ways:  it 
could mean that phosphorylation at each corresponding phosphorylatable serine 
or threonine is critical for function and may indeed depend upon proline-directed 
kinase phosphorylation or that disruption of these prolines may simply affect the 
protein structurally. 
Since phosphorylation at these sites likely plays a role in Mtrm function, we 
examined the functionality of the phospho-mimic mutants MtrmT40E, MtrmS48E, 
and MtrmS52E with respect to homologous achiasmate segregation.  None of 
the phospho-mimic Mtrm mutants were able to rescue functionality (data not 
shown).  These data suggest that either the phospho-mimetic was not successful 
or perhaps that phosphorylation at MtrmT40, MtrmS48 and MtrmS52 must be 
dynamic for proper protein functionality. 
Finally, we demonstrate that residues that fall within the region of 
conservation just proximal to the SAM domain also appear critical for Mtrm 
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function.  Whether or not these mediate a transient interaction between Mtrm and 
Polo remains unclear, but it appears that many levels of complexity remain to be 
elucidated regarding Mtrm functionality. 
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4.8 Materials and Methods 
 Site directed mutants and fly transgenes were generated as described in 
Chapter 3. 
Drosophila stocks 
 Throughout this chapter, y w ; spapol was used as the wild-type strain.  For 
achiasmate X chromosome studies, y w/FM7 was used as our wild-type control, 
and a recombinant version of chromosome 3 where the nanos-GAL4 driver and 
mtrm126 were recombined together [60].  The deficiency stock Df(3L)66C-T2-T10 
[59], and the mutant polo alleles, poloKG03033 and polo16-1 (available from the 
Bloomington Drosophila Stock Center), were used for the co-suppression 
assays. 
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Achiasmate Chromosome NDJ assays 
Transgene-bearing males from each transgenic line were crossed to y w ; 
spapol  and resulting y w ; transgene/+ ; spapol  females were then crossed to 
either FM7/y+Y ; nanos-GAL4-mtrm126 ; spapol  males or FM7/y+Y ; nanos-GAL4 ; 
spapol males to generate y w/FM7 ; transgene/+ ; nanos-GAL4-mtrm126/+ ; spapol  
tester females or y w/FM7 ; transgene/+ ; nanos-GAL4/+ ; spapol  tester females.  
Corresponding internal control female siblings of the same genotype but lacking 
the transgene were also collected and tested for each case, and those internal 
controls are reflected cumulatively.  For each line, we scored at least 10 such 
tester females individually crossed to attached –XY, y+ v f B; C(4), ci eyR males, 
and assessed the frequency of X chromosome nondisjunction at meiosis I as 
described in [59,76]. 
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Chapter 5.    Residues and regions of Mtrm critical for 
proper oocyte development 
5.1 Introduction 
With the exception of the MtrmSAMDEL mutant, the results presented in 
Chapters 2, 3 and 4 suggest a strong correlation between the ability of various 
mutant versions of Mtrm to physically interact with Polo and their ability to rescue 
homologous achiasmate segregation defects in mtrm heterozygotes.  By in large, 
mutants able to interact with Polo kinase also rescued achiasmate NDJ, while 
mutants that failed to bind Polo resulted in high levels of chromosome mis-
segregation.  However, analysis of the MtrmSAMDEL mutant revealed that while 
the C-terminal SAM domain is required together with specific Mtrm residues for 
robust physical interaction with Polo, it is dispensable in the context of 
chromosome segregation. Taken together, these observations suggest that a 
transient interaction between the region proximal to the SAM domain of Mtrm and 
Polo may be sufficient for the process of homologous achiasmate segregation.  
But what, then, is the purpose of the robust interaction observed between Mtrm 
and Polo during Drosophila female meiosis?   
This chapter addresses this question by examining whether our series of 
site-specifically integrated mtrm transgenes rescue the failure of fertilized eggs to 
hatch from females completely lacking endogenous mtrm, —a phenotype initially 
reported in 2003 [59].  The defect in egg hatchability is not definitively linked to 
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Polo kinase mis-regulation.  However, previous work has demonstrated that 
females lacking sufficient doses of mtrm exhibit a dosage-dependent early onset 
of nuclear envelope breakdown (NEB) that is suppressed by simultaneous 
reduction of the polo gene [60].  Precocious NEB at this stage may result in 
release of an incompletely or inappropriately re-compacted karyosome—a 
spherical cluster that meiotic chromosomes form within the oocyte nucleus that is 
thought to normally facilitate proper spindle formation following NEB.  Consistent 
with this view, mtrm heterozygotes also exhibit karyosome defects both before 
and after NEB that can be rescued by simultaneous reduction in the polo gene 
[60].  Intriguingly, abnormal karyosome morphology is highly correlated with 
female sterility [90,91].  Therefore, the sterility observed in females lacking mtrm 
could be due karyosome defects so severe that the oocyte is unable to recover 
and build a spindle.   Alternatively, early onset of NEB could also cause other 
deleterious problems for the chromosomes of the oocyte related to the lack of or 
persistence of incorrect cell cycle factors present or absent at that time. 
5.2 Components of all three conserved regions of Mtrm are 
required for proper oocyte development 
In order to determine whether our mutant versions of mtrm are able to 
rescue the sterility observed in females lacking endogenous mtrm, we introduced 
our transgenes into females trans-heterozygous for two null alleles of mtrm:  the 
nanos-GAL4, mtrm126 chromosome and a deficiency that uncovers the mtrm 
gene (Df(3L)66C-T2-T10).  As a negative internal control, we also tested siblings 
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lacking the transgene from each cross confirm the sterility phenotype.  The 
results of this analysis are shown in Table 5.1.  In general, the data demonstrate 
a strong correlation between the ability of specific Mtrm mutants to physically 
interact with Polo with their ability to rescue sterility in mtrm trans-heterozygotes.  
Components of all three regions of evolutionary conservation—the STP region, 
the region proximal to the SAM domain, and the C-terminal SAM domain are 
critical for fertility.  We interpret these data to mean that robust physical 
interaction between Mtrm and Polo is required for female fertility, perhaps by 
facilitating proper maintenance of karyosome morphology and/or ensuring proper 
timing of NEB. 
 
 In addition to examining this phenotype in a mtrm null background, we 
were also interested in knowing whether mtrm heterozygotes displayed reduced 
fertility.  We determined egg hatchability rates from females of the following 
genotypes w1118 (control), y w ; nanos-GAL4, mtrm126/+ and various mtrm 
Table 5-1  Fertility screen of Mtrm truncations and amino acid to alanine Mtrm mutants 
expressed in females lacking endogenous mtrm. 
Females trans-heterozygous for the nanos-GAL4, mtrm126 chromosome and a deficiency that 
uncovers the mtrm gene (Df(3L)66C-T2-T10)  expressing mtrm transgenes with the indicated 
mutations were screened for fertility.  Siblings from each cross lacking the transgene were used 
as internal controls.   
- 
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transgenes in a y w ; nanos-GAL4, mtrm126/(Df(3L)66C-T2-T10) background 
(Table 5-2).  Perhaps not surprisingly, the fertility of mtrm heterozygotes was 
reduced by approximately half compared to wild type.  This finding is consistent 
with previous work that demonstrated that mtrm heterozygotes displayed defects 
in both proper timing of NEB and maintenance of karyosome architecture [60].  
Perhaps the NEB and/or karyosome defects lead to a reduced egg hatch rate.  In 
a mtrm null background, introduction of a 3XFLAG-FLMtrm transgene rescues 
the defects in fertility to a rate similar to that of the mtrm heterozygotes.  
Importantly, consistent with our general screen, neither point mutations in key 
Mtrm residues nor deletion of the C-terminal SAM domain restores fertility.   
5.3 Discussion 
The results described in this chapter suggest that we have identified a 
separation-of-function mutant involving the C-terminal SAM domain of Mtrm.  
While dispensable for homologous achiasmate segregation, the C-terminal SAM 
domain appears critical for proper oocyte development as assayed by its inability 
Table 5-2  Egg Hatchability rates of females heterozygous for a null allele of mtrm and of 
key Mtrm mutants expressed in females lacking endogenous mtrm. 
Egg hatch rates were determined for the genotypes listed below 
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to rescue female fertility in a mtrm trans-heterozygote background.  Females 
heterozygous for a null allele of mtrm display both improper timing of NEB and 
abnormal karyosome morphology, which is highly correlated with female sterility. 
Hence, we speculate that the sterility observed in females trans-heterozygous for 
mtrm may be due to severe, irreversible karyosome defects and/or early onset of 
NEB resulting in the release of an improperly compacted karyosome that cannot 
recover.  Because these phenotypes are in fact observed in mtrm heterozygotes 
and both can be rescued by simultaneously decreasing the dosage of polo [60], 
we speculate that the sterility observed in females lacking mtrm may be linked to 
Polo mis-regulation.   
Several conserved Mtrm residues proximal to the SAM domain in addition 
to the SAM domain itself are required together for robust interaction with Polo in 
vivo.  We speculate that this robust interaction between Mtrm and Polo is 
necessary for maintenance of the karyosome, and complete failure of physical 
interaction with Polo results in karyosome instability and sterility.  However, 
future studies to address this will be necessary.  We propose that the interaction 
between Mtrm and Polo is first established by residues proximal to the SAM 
domain, which is sufficient for function as assayed by homologous achiasmate 
segregation.  However, maintenance of this interaction must also involve the C-
terminal SAM domain, which may be required for some other meiotic process 
such as karyosome maintenance as speculated in this chapter.   
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5.5 Materials and Methods 
Fertility assays 
To screen for the ability of our mutant lines to rescue sterility, transgene-
bearing females from each transgenic line also balanced for Chromosome 3 
were crossed to y w/y+Y ; Df(3L)66C-T2-10/TM3 ; spapol males.  Resulting y w ; 
transgene/+ ; Df(3L)66C-T2-10/TM3 ; spapol females were then crossed to y 
w/y+Y ; nanos-GAL4, mtrm126 ; spapol  males to generate y w; transgene/+ ; 
nanos-GAL4, mtrm126/ Df(3L)66C-T2-10; spapol  tester females and y w ; nanos-
GAL4-mtrm126/ Df(3L)66C-T2-10; spapol control siblings.  At least 10 females per 
genotype per mutant line were placed in vials with wild type w1118 males, and 
fertility was determined 7 days later by presence or absence of larvae. 
Egg hatchability assays 
To determine egg hatch rate, tester females either with or without a mtrm 
transgene in a nanos-GAL4, mtrm126/Df(3L)66C-T2-10 trans-heterozygote 
background were yeasted and placed with wild type males for 2 days. Males and 
 
 
 96 
females were then placed in grape plate cages and allowed to lay eggs for 8 
hours, at which point the adults were removed and the eggs were counted. Two 
days later unhatched eggs were counted. 
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Chapter 6.  Conclusions, Perspectives and Future 
Directions 
This thesis examines the detailed mechanism by which Mtrm physically 
interacts with Polo kinase to regulate Polo function during Drosophila female 
meiosis to ensure proper homologous achiasmate segregation and oocyte 
development.  We are interested in understanding the nature of this interaction, 
since a more complex view of how Polo kinase is controlled by its protein 
partners has recently emerged.  This view is consistent with the observation that 
Polo kinase promotes a diverse set of molecular events during cell division—
likely a consequence of its complex regulation as exemplified by the sheer 
number of regulatory partners that have been discovered and the varied 
mechanisms of interaction that have been found.  From a clinical standpoint, 
understanding the intricacies of post-translational Polo kinase regulatory 
interactions may help drive innovative strategies for targeted Polo kinase 
inhibition in cancer cells. 
Previous work demonstrated that a physical interaction exists between 
Mtrm and Polo involving the central residue of a Polo PBD binding motif within 
Mtrm [60].  This led to the speculation that Mtrm and Polo may engage in a 
canonical mechanism of interaction, where phosphorylation of the central 
residue, MtrmT40, allows for subsequent Polo PBD binding through a well 
characterized positively charged cleft at the interface of the two C-terminal Polo 
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boxes, PB1 and PB2, mediated by two residues essential for PBD selectivity—
namely PoloH518 and PoloK520.  Post-translational modification (PTM) analysis 
of Mtrm supported this view, as MtrmT40 is phosphorylated at high levels in the 
fly ovary.  However, PTM analysis also demonstrated that other absolutely 
conserved residues are also phosphorylated at high levels in vivo, including 
MtrmS48 and MtrmS52.  These observations raise the intriguing possibility that 
additional sites play a role in mediating the physical interaction between Mtrm 
and Polo. Since these residues may be phosphorylated by a distinct kinase, 
regulation of Polo binding due to phosphorylation of these residues adds an 
additional layer of complexity to the control of meiotic processes by Polo.  
Furthermore, little was known about the functionality of the C-terminal SAM 
domain of Mtrm, specifically whether it played a role in mediating the physical 
interaction with Polo or other proteins (including Mtrm itself), or whether it 
mediated some other role independent of Polo binding during Drosophila female 
meiosis.   
Prior work also demonstrated that mtrm and polo were genetically linked, 
and that this interaction was important for ensuring proper homologous 
achiasmate segregation and oocyte development [60].  Interestingly, these 
phenotypes were possibly separable, albeit both potentially Polo-mediated.  
However, a separation-of-function mutant allele of mtrm or polo had not been 
identified, and it remained unknown as to whether disruption of chromosome 
segregation results in defects in oocyte development or vice versa.  Alternatively, 
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the phenotypes observed in mtrm and polo mutants may simply reflect the 
dependency of the two pathways. 
The results presented in this thesis have shed light on a number of these 
questions.  First, we demonstrate that Mtrm may engage in a novel mechanism 
of interaction with Polo kinase.  Not only are additional Mtrm residues such as 
MtrmS48 and Mtrm52 required for robust physical interaction with Polo kinase, 
but Mtrm may interact with Polo kinase by a novel mechanism that fails to be 
perturbed by ablation of Polo residues known to be required for canonical PBD 
specificity.  This finding is reminiscent of a report that describes the interaction 
between Dbf4 and the yeast Polo homolog, Cdc5 [56].  However, unlike the 
Dbf4-Cdc5 interaction, the Mtrm-Polo interaction appears to be phospho-
dependent.   
Second, we have made several interesting findings regarding the 
functionality of the C-terminal SAM domain of Mtrm.  We demonstrate that at 
least one role of the SAM domain is to mediate the vast majority of protein-
protein interactions observed during Drosophila female meiosis as identified by 
MudPIT analysis.  The SAM domain also appears critical for the physical 
interaction of Mtrm with Polo.  Furthermore, we present the first evidence that 
Mtrm may interact with itself via the SAM domain and speculate that perhaps this 
self-interaction may play a role in the ability of Mtrm to robustly interact with Polo 
kinase and/or Mtrm’s role in oocyte development.  Further experiments are 
necessary to elucidate whether this is the case.  In a general sense, the 
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interaction between Mtrm and Polo can be considered to join a growing list of 
regulatory proteins including Map205, Dbf4 and Bora, which interact with Polo via 
some non-canonical mechanism (see Figure 6-1 for working model). 
Finally, we were able to identify a separation-of-function allele of mtrm that 
involves the SAM domain.  While dispensable for proper chromosome 
segregation, this domain is critical for oocyte development, raising an entirely 
new array of intriguing questions regarding Mtrm function during Drosophila 
female meiosis.  Additionally, the identification of a separation-of-function mutant 
               
Figure 6-1  A working model for how Mtrm may regulate Polo kinase through 
physical interaction.  
Depicted is a working model to explain the relationship between Mtrm and Polo and 
how they may coordinate homologous achiasmate segregation and proper oocyte 
development during Drosophila female meiosis.  The affinity for Polo to Mtrm is first 
initiated by the region proximal to the C-terminal SAM domain.  This transient 
interaction is sufficient for ensuring proper homologous achiasmate segregation.  It is 
also a necessary step for allowing the subsequent more robust physical interaction 
facilitated by the C-terminal SAM domain, which is required for proper oocyte 
development as assayed by female fertility.  
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could potentially be an extremely useful tool for elucidating the mechanisms by 
which Polo can activate different pathways at different times during cell division.  
We have recently begun fluorescence cross-correlation studies of fluorescently 
labelled versions of Mtrm, including a truncated version of Mtrm that deletes the 
SAM domain, and Polo expressed under their respective native promoters in the 
fly germline.  Due to the anatomy of the Drosophila ovariole and distinct 
morphology of oocytes at different stages of development, we will be able to 
examine the physical interaction between Mtrm and Polo throughout meiotic 
progression—identifying the exact stage when Mtrm and Polo appear to interact, 
as well as to potentially be able to detect more transient interactions that might 
otherwise go unidentified between Polo and Mtrm.  These experiments and 
others will certainly further our understanding of the mechanism of the interaction 
between Mtrm and Polo. 
6.1 Unravelling the intricate Mtrm regulation of Polo with 
simple yeast 
The first evidence demonstrating that Mtrm may interact with Polo by a non-
canonical mechanism came from our Y2H studies.  Indeed, the fact that our 
findings in yeast largely correlate with our findings in the fly support the view that 
heterologous expression of Mtrm and Polo in yeast is a valid method for future 
studies of the mechanism of interaction between these two proteins.  
Furthermore, while mutational studies of Polo kinase in the fly are ongoing, the 
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analogous studies in yeast presented here can be used to predict the probable 
outcomes of those experiments.  
Pending the correlation of those outcomes and given the relative speed of 
the system, it would be feasible to consider returning to Y2H as a means to 
dissect at a finer scale the residues and regions of both Mtrm and Polo that are 
critical for their physical interaction.  Incorporating the point mutations discussed 
in this work would provide additional opportunities by which to confirm that the 
data collected using these two systems are largely congruent.  Furthermore, it 
would be advantageous to utilize the Y2H as a rapid means to perform additional 
truncation analyses in parallel.  These analyses may identify more precisely the 
regions of Polo and Mtrm that are capable of interacting.   These experiments 
may give rise to likely candidates for post-translational modifications or identify 
novel regulatory domains through a scanning mutagenesis approach. However, 
this type of approach is not without caveats. The strategy to replace any residue 
with an alanine or remove peptide stretches may grossly alter the overall 
structure of the protein. At least for Mtrm, this caveat may be minimized, as much 
of the protein is predicted to be intrinsically unstructured.  We may also fail to 
predict important aspects of regulation if the molecular mechanisms responsible 
for some post-translational modifications do not occur properly in S. cerevisiae; 
our observation that MtrmT40 is not phosphorylated in yeast exemplifies this 
point.  However, the fact that the yeast system was able to accurately predict 
virtually all of the important binding interactions between Mtrm and Polo that we 
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later verified in the fly demonstrates the utility of the Y2H system for rapid 
screening and analysis of Mtrm and Polo binding 
6.2 In vivo studies of Mtrm and Polo associations 
While the yeast system was valuable to understand the fundamentals of the 
Mtrm-Polo interaction, it was essential to validate and extend our findings within 
the context Drosophila female meiosis.   We did this by extensive proteomic 
analysis of Mtrm, and our proteomic results of Mtrm posed interesting questions 
in addition to validating the interaction between Mtrm and Polo characterized via 
the Y2H assay. While our MudPIT analysis of Mtrm expressed in S. cerevisiae 
exposed no new protein partners, albeit that Mtrm was expressed in the absence 
of Drosophila Polo.  Mass spectroscopy of samples purified from transgenic flies 
indicated that Mtrm-Polo intermingle with an array of complexes. What is the 
significance of each of these associations?  Are they required for the correct 
folding of Mtrm and Polo, either as separate identities or together as a joint 
complex? Do they act as co-activators or inhibitors stimulating/hindering a 
specific activity (and what is that activity)? Or does the Mtrm-Polo complex 
somehow modulate their cellular roles?  For example, PLGEM analysis of Mtrm 
purified from the fly ovary revealed that only four proteins co-purified with a p 
value of less than or equal to .001—Polo kinase, Heat shock protein 23, Heat 
shock protein 26, and Heat shock protein 27.  Are chaperones required to 
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facilitate the formation and/or stabilization of the Mtrm-Polo complex?  These 
questions and others could be addressed in future studies.  
In parallel to the experiments described in this thesis, we initiated the 
ground work for in vitro studies by establishing recombinant Mtrm and Polo 
expression in Drosophila Schneider (S2) cells as well as in the Sf9 cell – 
baculovirus system.  Preliminary experiments for these approaches gave 
unanticipated results--Mtrm and Polo could be not co-purified from transfected 
S2 cell extract nor from a mixture of two Sf9 extracts, each from a single infection 
of either Mtrm or Polo. Consistent with trends seen by others using baculovirus 
for recombinant protein expression, a Mtrm-Polo complex could be isolated if 
insect cells were co-infected with both Mtrm and Polo containing virus. While 
encouraged by this outcome, we were puzzled when we could co-purify Polo with 
a several of Mtrm mutants including MtrmT40A and MtrmS48A that were 
predicted not to be binding partners in the Y2H assay or by MudPIT analysis and 
could not rescue achiasmic chromosome segregation defect nor sterility 
phenotype of Drosophila mtrm mutants. 
If Mtrm-Polo interaction depends on the cell cycle, we may reconcile the 
seemingly incongruent observations described above. Transfection of S2 cells is 
performed when cells are highly confluent and hence expression of proteins 
occurs as confluency-induced cell cycle exit occurs or as they are arrested in 
G0/G1.  Infection of Sf9 cells with baculovirus also halts growth of cells, but the 
cell cycle arrests in G2/M. In this light, Polo-associated Mtrm may be able to be 
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purified from starting material sourced from transfected Drosophila S2 cells that 
have been synchronised and are in G2/M. 
6.3 Genetic screens to identify dominant suppressors of 
female sterility and homologous achiasmate segregation 
We speculate that phosphorylation plays a key role in controlling the 
interaction between Mtrm and Polo.  Additionally, other interactors likely play a 
role in facilitating the functional interaction between these two proteins. 
Identifying regulators that modify Mtrm or Polo thus facilitating their affinity for 
one another or other proteins that somehow play a role in mediating this 
interaction would elucidate another layer of Polo regulation as well as advance 
our efforts to examine Drosophila female meiotic processes such as homologous 
achiasmate segregation at a molecular level.   One extremely powerful way to 
identify such regulators is to perform genetic screens for dominant suppressors 
of our phenotypes of interest.  Because the homologous chromosome 
segregation defect is so severe in females heterozygous for a null allele of mtrm, 
one could feasibly design a screen to look for modifiers that suppresses this 
phenotype.  Additionally, one could imagine performing a selection for 
suppressors of the oocyte development phenotype that results in eggs that do 
not hatch. Furthermore, it would be interesting to perform a selection that 
suppresses the sterility females lacking endogenous mtrm but containing 
MtrmSAMDEL mutant protein.  Such a selection may identify interactors that are 
involved in the sterility defect but not the achiasmate NDJ phenotype. 
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The ease of screening for suppressors of sterility cannot be over stated. 
One caveat to this selection however, would be recovering non-specific 
suppressors.  This could be circumvented by the use of appropriate secondary 
screens, such as examination of achiasmate NDJ in heterozygotes, which is a 
common phenotype in meiotic regulators and has been used extensively as a 
criterion for isolation of mutants that affect meiotic progression. 
6.4 From yeast and flies to humans  
We have an opportunity to look to nature for as a source of inspiration to 
solve problems faced by humans involving the fundamental process 
chromosome segregation.  Here we examine Mtrm, a negative regulator of highly 
conserve Polo kinase during Drosophila female meiosis.  Our hope is that these 
studies will eventually lead to new insights into the varied mechanisms of human 
Polo regulation and perhaps contribute to new and innovative strategies for 
targeted inhibition of Polo as an anti-cancer therapeutic.   
In addition, aneuploidy is a critical issue in human reproductive biology.  We 
have linked Polo regulation to the special process of homologous achiasmate 
segregation.  Because Chromosome 21 in humans has been reported to fail to 
recombine at a much higher frequency than expected, we suspect that, like flies, 
human female meiosis also engages in homologous achiasmate segregation.  
Perhaps this system is perturbed as women age, leading to the observed 
increased rate of births of children with trisomy 21.  This research raises many 
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questions.  Although Mtrm orthologs have not been found in humans, does Polo 
kinase play a similar role in humans and if so, what regulatory protein plays the 
analogous role of Mtrm?  Clearly, novel approaches are needed to address this 
question.  However, using power of well-established model organisms such as 
yeast and fly, clever genetic analysis and cutting-edge proteomic technology will 
certainly drive us forward toward this end. 
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